<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38672245</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>17</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Fibrinaloid Microclots and Atrial Fibrillation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">891</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12040891</ELocationID><Abstract><AbstractText>Atrial fibrillation (AF) is a comorbidity of a variety of other chronic, inflammatory diseases for which fibrinaloid microclots are a known accompaniment (and in some cases, a cause, with a mechanistic basis). Clots are, of course, a well-known <i>consequence</i> of atrial fibrillation. We here ask the question whether the fibrinaloid microclots seen in plasma or serum may in fact also be a cause of (or contributor to) the development of AF. We consider known 'risk factors' for AF, and in particular, exogenous stimuli such as infection and air pollution by particulates, both of which are known to cause AF. The external accompaniments of both bacterial (lipopolysaccharide and lipoteichoic acids) and viral (SARS-CoV-2 spike protein) infections are known to stimulate fibrinaloid microclots when added in vitro, and fibrinaloid microclots, as with other amyloid proteins, can be cytotoxic, both by inducing hypoxia/reperfusion and by other means. Strokes and thromboembolisms are also common consequences of AF. Consequently, taking a systems approach, we review the considerable evidence in detail, which leads us to suggest that it is likely that microclots may well have an aetiological role in the development of AF. This has significant mechanistic and therapeutic implications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0001-5838-7963</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown St, Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, S&#xf8;ltofts Plads, Building 220, 2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Private Bag X1 Matieland, Stellenbosch 7602, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lip</LastName><ForeName>Gregory Y H</ForeName><Initials>GYH</Initials><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool L7 8TX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9108-2384</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown St, Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Private Bag X1 Matieland, Stellenbosch 7602, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">arrhythmias</Keyword><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">fibrinaloid microclots</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">particulate matter</Keyword><Keyword MajorTopicYN="N">pollution</Keyword></KeywordList><CoiStatement>E.P. has a patent on the use of fluorescence methods for the detection of microclots in Long COVID. The authors declare no other conflicts on interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38672245</ArticleId><ArticleId IdType="pmc">PMC11048249</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12040891</ArticleId><ArticleId IdType="pii">biomedicines12040891</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E.J., Gillum R.F., Kim Y.H., McAnulty J.H., Jr., Zheng Z.J., et al. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014;129:837&#x2013;847. doi: 10.1161/CIRCULATIONAHA.113.005119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.005119</ArticleId><ArticleId IdType="pmc">PMC4151302</ArticleId><ArticleId IdType="pubmed">24345399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulkifly H., Lip G.Y.H., Lane D.A. Epidemiology of atrial fibrillation. Int. J. Clin. Pract. 2018;72:e13070. doi: 10.1111/ijcp.13070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13070</ArticleId><ArticleId IdType="pubmed">29493854</ArticleId></ArticleIdList></Reference><Reference><Citation>Corica B., Bonini N., Imberti J.F., Romiti G.F., Vitolo M., Attanasio L., Basili S., Freedman B., Potpara T.S., Boriani G., et al. Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: A comprehensive review of current evidence. Eur. Heart J. Open. 2023;3:oead031. doi: 10.1093/ehjopen/oead031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjopen/oead031</ArticleId><ArticleId IdType="pmc">PMC10083691</ArticleId><ArticleId IdType="pubmed">37051263</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin E.J., Wolf P.A., D&#x2019;Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation. 1998;98:946&#x2013;952. doi: 10.1161/01.CIR.98.10.946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.98.10.946</ArticleId><ArticleId IdType="pubmed">9737513</ArticleId></ArticleIdList></Reference><Reference><Citation>Staerk L., Sherer J.A., Ko D., Benjamin E.J., Helm R.H. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ. Res. 2017;120:1501&#x2013;1517. doi: 10.1161/CIRCRESAHA.117.309732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.309732</ArticleId><ArticleId IdType="pmc">PMC5500874</ArticleId><ArticleId IdType="pubmed">28450367</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai H., Zhang Q., Much A.A., Maor E., Segev A., Beinart R., Adawi S., Lu Y., Bragazzi N.L., Wu J. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990&#x2013;2017: Results from the Global Burden of Disease Study 2017. Eur. Heart J. Qual. Care Clin. Outcomes. 2021;7:574&#x2013;582. doi: 10.1093/ehjqcco/qcaa061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcaa061</ArticleId><ArticleId IdType="pmc">PMC8557444</ArticleId><ArticleId IdType="pubmed">32735316</ArticleId></ArticleIdList></Reference><Reference><Citation>Okafor C., Byrnes J., Stewart S., Scuffham P., Afoakwah C. Cost Effectiveness of Strategies to Manage Atrial Fibrillation in Middle- and High-Income Countries: A Systematic Review. Pharmacoeconomics. 2023;41:913&#x2013;943. doi: 10.1007/s40273-023-01276-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-023-01276-5</ArticleId><ArticleId IdType="pmc">PMC10322963</ArticleId><ArticleId IdType="pubmed">37204698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T., Ye M., Lei F., Qin J.J., Liu Y.M., Chen Z., Chen M.M., Yang C., Zhang P., Ji Y.X., et al. Prevalence and trend of atrial fibrillation and its associated risk factors among the population from nationwide health check-up centers in China, 2012&#x2013;2017. Front. Cardiovasc. Med. 2023;10:1151575. doi: 10.3389/fcvm.2023.1151575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1151575</ArticleId><ArticleId IdType="pmc">PMC10264614</ArticleId><ArticleId IdType="pubmed">37324618</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho E.M., Lip G.Y.H. Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020&#x2013;2040. Eur. Heart J.-Qual. Care Clin. Outcomes. 2023:qcad055. doi: 10.1093/ehjqcco/qcad055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcad055</ArticleId><ArticleId IdType="pmc">PMC11187718</ArticleId><ArticleId IdType="pubmed">37697684</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P.G., Healey J.S., Raina P., Connolly S.J., Ibrahim Q., Gupta R., Avezum A., Dans A.L., Lopez-Jaramillo P., Yeates K., et al. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153,152 middle-aged individuals. Cardiovasc. Res. 2021;117:1523&#x2013;1531. doi: 10.1093/cvr/cvaa241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa241</ArticleId><ArticleId IdType="pubmed">32777820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomstrom-Lundqvist C., Boriani G., Castella M., Dan G.A., Dilaveris P.E., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021;42:373&#x2013;498. doi: 10.1093/eurheartj/ehaa612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa612</ArticleId><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Genaidy A., Tran G., Marroquin P., Estes C., Sloop S. Improving Stroke Risk Prediction in the General Population: A Comparative Assessment of Common Clinical Rules, a New Multimorbid Index, and Machine-Learning-Based Algorithms. Thromb. Haemost. 2022;122:142&#x2013;150. doi: 10.1055/a-1467-2993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1467-2993</ArticleId><ArticleId IdType="pubmed">33765685</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Li S., Liu X., Lip G.Y.H., Guo L., Zhu W. Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis. Thromb. Haemost. 2023 doi: 10.1055/s-0043-1770724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1770724</ArticleId><ArticleId IdType="pubmed">37399842</ArticleId></ArticleIdList></Reference><Reference><Citation>Treewaree S., Lip G.Y.H., Krittayaphong R. Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry. Thromb. Haemost. 2024;124:69&#x2013;79. doi: 10.1055/s-0043-1772773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1772773</ArticleId><ArticleId IdType="pubmed">37625457</ArticleId></ArticleIdList></Reference><Reference><Citation>Romiti G.F., Proietti M., Bonini N., Ding W.Y., Boriani G., Huisman M.V., Lip G.Y.H., Investigators G.-A. Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III. Thromb. Haemost. 2022;122:2030&#x2013;2041. doi: 10.1055/s-0042-1756355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1756355</ArticleId><ArticleId IdType="pubmed">36037828</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao C.W., Aday A.W., Almarzooq Z.I., Anderson C.A.M., Arora P., Avery C.L., Baker-Smith C.M., Beaton A.Z., Boehme A.K., Buxton A.E., et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023;147:e93&#x2013;e621. doi: 10.1161/CIR.0000000000001123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001123</ArticleId><ArticleId IdType="pubmed">36695182</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshehri A.M. Stroke in atrial fibrillation: Review of risk stratification and preventive therapy. J. Fam. Community Med. 2019;26:92&#x2013;97. doi: 10.4103/jfcm.JFCM_99_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfcm.JFCM_99_18</ArticleId><ArticleId IdType="pmc">PMC6515763</ArticleId><ArticleId IdType="pubmed">31143079</ArticleId></ArticleIdList></Reference><Reference><Citation>Son M.K., Lim N.K., Kim H.W., Park H.Y. Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort. PLoS ONE. 2017;12:e0179687. doi: 10.1371/journal.pone.0179687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179687</ArticleId><ArticleId IdType="pmc">PMC5479557</ArticleId><ArticleId IdType="pubmed">28636620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22:983&#x2013;988. doi: 10.1161/01.STR.22.8.983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.22.8.983</ArticleId><ArticleId IdType="pubmed">1866765</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini C., De Santis F., Sacco S., Russo T., Olivieri L., Totaro R., Carolei A. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study. Stroke. 2005;36:1115&#x2013;1119. doi: 10.1161/01.STR.0000166053.83476.4a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000166053.83476.4a</ArticleId><ArticleId IdType="pubmed">15879330</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnabel R.B., Haeusler K.G., Healey J.S., Freedman B., Boriani G., Brachmann J., Brandes A., Bustamante A., Casadei B., Crijns H., et al. Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. Circulation. 2019;140:1834&#x2013;1850. doi: 10.1161/CIRCULATIONAHA.119.040267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.040267</ArticleId><ArticleId IdType="pubmed">31765261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Lane D.A., Lenarczyk R., Boriani G., Doehner W., Benjamin L.A., Fisher M., Lowe D., Sacco R.L., Schnabel R., et al. Integrated care for optimizing the management of stroke and associated heart disease: A position paper of the European Society of Cardiology Council on Stroke. Eur. Heart J. 2022;43:2442&#x2013;2460. doi: 10.1093/eurheartj/ehac245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac245</ArticleId><ArticleId IdType="pmc">PMC9259378</ArticleId><ArticleId IdType="pubmed">35552401</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi A., Lip G.Y.H., Nordsletten D.A., Williams S.E., Aslanidi O., de Vecchi A. Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke. Front. Cardiovasc. Med. 2022;9:1074562. doi: 10.3389/fcvm.2022.1074562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1074562</ArticleId><ArticleId IdType="pmc">PMC9887999</ArticleId><ArticleId IdType="pubmed">36733827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdemir H., Sagris D., Lip G.Y.H., Abdul-Rahim A.H. Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias. Curr. Cardiol. Rep. 2023;25:357&#x2013;369. doi: 10.1007/s11886-023-01862-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-023-01862-1</ArticleId><ArticleId IdType="pubmed">36976496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Coronary heart disease and atrial fibrillation: The Framingham Study. Am. Heart J. 1983;106:389&#x2013;396. doi: 10.1016/0002-8703(83)90208-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(83)90208-9</ArticleId><ArticleId IdType="pubmed">6869222</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdin C.A., Wong C.X., Hsiao A.J., Altman D.G., Peters S.A.E., Woodward M., Odutayo A.A. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: Systematic review and meta-analysis of cohort studies. BMJ. 2016;532:h7013. doi: 10.1136/bmj.h7013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h7013</ArticleId><ArticleId IdType="pmc">PMC5482349</ArticleId><ArticleId IdType="pubmed">26786546</ArticleId></ArticleIdList></Reference><Reference><Citation>Odutayo A., Wong C.X., Hsiao A.J., Hopewell S., Altman D.G., Emdin C.A. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: Systematic review and meta-analysis. BMJ. 2016;354:i4482. doi: 10.1136/bmj.i4482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4482</ArticleId><ArticleId IdType="pubmed">27599725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruddox V., Sandven I., Munkhaugen J., Skattebu J., Edvardsen T., Otterstad J.E. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 2017;24:1555&#x2013;1566. doi: 10.1177/2047487317715769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487317715769</ArticleId><ArticleId IdType="pmc">PMC5598874</ArticleId><ArticleId IdType="pubmed">28617620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Lenarczyk R., Pastori D., Ntaios G., Doehner W., Schnabel R.B. Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments. Curr. Probl. Cardiol. 2023;48:101738. doi: 10.1016/j.cpcardiol.2023.101738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2023.101738</ArticleId><ArticleId IdType="pubmed">37040854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sposato L.A., Cipriano L.E., Saposnik G., Ruiz Vargas E., Riccio P.M., Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: A systematic review and meta-analysis. Lancet Neurol. 2015;14:377&#x2013;387. doi: 10.1016/S1474-4422(15)70027-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)70027-X</ArticleId><ArticleId IdType="pubmed">25748102</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X.M., Rao Z.Z., Gu H.Q., Zhao X.Q., Wang C.J., Liu L.P., Liu C., Wang Y.L., Li Z.X., Xiao R.P., et al. Atrial Fibrillation Known before or Detected after Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death. Stroke. 2019;50:1124&#x2013;1129. doi: 10.1161/STROKEAHA.118.024176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.118.024176</ArticleId><ArticleId IdType="pubmed">31009353</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur M., Alsinbili A., Chattopadhyay R., Warburton E.A., Khadjooi K., Induruwa I. Identifying the optimal time period for detection of atrial fibrillation after ischaemic stroke and TIA: An updated systematic review and meta-analysis of randomized control trials. Int. J. Stroke. 2023;30:17474930231215277. doi: 10.1177/17474930231215277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17474930231215277</ArticleId><ArticleId IdType="pubmed">37947341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalarus Z., Mairesse G.H., Sokal A., Boriani G., Sredniawa B., Casado-Arroyo R., Wachter R., Frommeyer G., Traykov V., Dagres N., et al. Searching for atrial fibrillation: Looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper. Europace. 2023;25:185&#x2013;198. doi: 10.1093/europace/euac144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euac144</ArticleId><ArticleId IdType="pmc">PMC10112840</ArticleId><ArticleId IdType="pubmed">36256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Mbotwe S., Bester J., Robinson C.J., Kell D.B. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide. J. R. Soc. Interface. 2016;123:20160539. doi: 10.1098/rsif.2016.0539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2016.0539</ArticleId><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A., Vlok M., Turner S., Venter C., Laubscher G.J., Kell D.B., Pretorius E. Proteomics of fibrin amyloid microclots in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 2022;21:190. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: Lessons from and for blood clotting. Prog. Biophys. Mol. Biol. 2017;123:16&#x2013;41. doi: 10.1016/j.pbiomolbio.2016.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2016.08.006</ArticleId><ArticleId IdType="pubmed">27554450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases? Biochem. J. 2023;480:1217&#x2013;1240. doi: 10.1042/BCJ20230241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20230241</ArticleId><ArticleId IdType="pubmed">37584410</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal G.M., Engelbrecht L., Davis T., de Villiers W.J.S., Kell D.B., Pretorius E. Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson&#x2019;s Disease, Alzheimer&#x2019;s Disease and Type 2 Diabetes Mellitus. Sci. Rep. 2018;8:16798. doi: 10.1038/s41598-018-35009-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35009-y</ArticleId><ArticleId IdType="pmc">PMC6235901</ArticleId><ArticleId IdType="pubmed">30429533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Mbotwe S., Kell D.B. Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson&#x2019;s disease. PLoS ONE. 2018;13:e0192121. doi: 10.1371/journal.pone.0192121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192121</ArticleId><ArticleId IdType="pmc">PMC5832207</ArticleId><ArticleId IdType="pubmed">29494603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Hendricks L., Nkosi N.B., Benson S.R., Kell D.B. Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: Assessment with novel Amytracker&#x2122; stains. J. R. Soc. Interface. 2018;15:20170941. doi: 10.1098/rsif.2017.0941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2017.0941</ArticleId><ArticleId IdType="pmc">PMC5832738</ArticleId><ArticleId IdType="pubmed">29445039</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bester J., Page M.J., Kell D.B. The potential of LPS-binding protein to reverse amyloid formation in plasma fibrin of individuals with Alzheimer-type dementia. Front. Aging Neurosci. 2018;10:257. doi: 10.3389/fnagi.2018.00257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00257</ArticleId><ArticleId IdType="pmc">PMC6113936</ArticleId><ArticleId IdType="pubmed">30186156</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19. Biosci. Rep. 2021;41:BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Kruger A., Venter C., Burger E.M., Laubscher G.J., Maponga T.G., Kotze M.J., Kwaan H.C., Miller J.B., Fulkerson D., et al. Relative hypercoagulopathy of the SARS-CoV-2 Beta and Delta variants when compared to the less severe Omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness. Semin. Thromb. Haemost. 2022;48:858&#x2013;868. doi: 10.1055/s-0042-1756306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1756306</ArticleId><ArticleId IdType="pubmed">36174604</ArticleId></ArticleIdList></Reference><Reference><Citation>Alon U. An Introduction to Systems Biology: Design Principles of Biological Circuits. Chapman and Hall/CRC; London, UK: 2006.</Citation></Reference><Reference><Citation>Kell D.B., Knowles J.D. The role of modeling in systems biology. In: Szallasi Z., Stelling J., Periwal V., editors. System Modeling in Cellular Biology: From Concepts to Nuts and Bolts. MIT Press; Cambridge, UK: 2006. pp. 3&#x2013;18.</Citation></Reference><Reference><Citation>Palsson B.&#xd8;. Systems Biology: Properties of Reconstructed Networks. Cambridge University Press; Cambridge, UK: 2006.</Citation></Reference><Reference><Citation>Klipp E., Herwig R., Kowald A., Wierling C., Lehrach H. Systems Biology in Practice: Concepts, Implementation and Clinical Application. Wiley/VCH; Berlin, Germany: 2005.</Citation></Reference><Reference><Citation>Buzan T. How to Mind Map. Thorsons; London, UK: 2002.</Citation></Reference><Reference><Citation>Hull D., Pettifer S.R., Kell D.B. Defrosting the digital library: Bibliographic tools for the next generation web. PLoS Comput. Biol. 2008;4:e1000204. doi: 10.1371/journal.pcbi.1000204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1000204</ArticleId><ArticleId IdType="pmc">PMC2568856</ArticleId><ArticleId IdType="pubmed">18974831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Kenny L.C. A dormant microbial component in the development of pre-eclampsia. Front. Med. Obs. Gynecol. 2016;3:60. doi: 10.3389/fmed.2016.00060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2016.00060</ArticleId><ArticleId IdType="pmc">PMC5126693</ArticleId><ArticleId IdType="pubmed">27965958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny L.C., Kell D.B. Immunological tolerance, pregnancy and pre-eclampsia: The roles of semen microbes and the father. Front. Med. Obs. Gynecol. 2018;4:239. doi: 10.3389/fmed.2017.00239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2017.00239</ArticleId><ArticleId IdType="pmc">PMC5758600</ArticleId><ArticleId IdType="pubmed">29354635</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilano V.L., Ota E., Ganchimeg T., Mori R., Souza J.P. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: A WHO secondary analysis. PLoS ONE. 2014;9:e91198. doi: 10.1371/journal.pone.0091198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0091198</ArticleId><ArticleId IdType="pmc">PMC3962376</ArticleId><ArticleId IdType="pubmed">24657964</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartsch E., Medcalf K.E., Park A.L., Ray J.G., High Risk of Pre-eclampsia Identification G. Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753. doi: 10.1136/bmj.i1753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i1753</ArticleId><ArticleId IdType="pmc">PMC4837230</ArticleId><ArticleId IdType="pubmed">27094586</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakou K., Evangelou E., Papatheodorou S.I. Genetic and non-genetic risk factors for pre-eclampsia: Umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet. Gynecol. 2018;51:720&#x2013;730. doi: 10.1002/uog.18959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.18959</ArticleId><ArticleId IdType="pubmed">29143991</ArticleId></ArticleIdList></Reference><Reference><Citation>Allotey J., Snell K.I.E., Smuk M., Hooper R., Chan C.L., Ahmed A., Chappell L.C., von Dadelszen P., Dodds J., Green M., et al. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: An individual participant data meta-analysis. Health Technol. Assess. 2020;24:72. doi: 10.3310/hta24720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta24720</ArticleId><ArticleId IdType="pmc">PMC7780127</ArticleId><ArticleId IdType="pubmed">33336645</ArticleId></ArticleIdList></Reference><Reference><Citation>Machano M.M., Joho A.A. Prevalence and risk factors associated with severe pre-eclampsia among postpartum women in Zanzibar: A cross-sectional study. BMC Public Health. 2020;20:1347. doi: 10.1186/s12889-020-09384-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09384-z</ArticleId><ArticleId IdType="pmc">PMC7650272</ArticleId><ArticleId IdType="pubmed">32887579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K., Brayboy L., Tripathi A. Pre-eclampsia: A Scoping Review of Risk Factors and Suggestions for Future Research Direction. Regen. Eng. Transl. Med. 2022;8:394&#x2013;406. doi: 10.1007/s40883-021-00243-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40883-021-00243-w</ArticleId><ArticleId IdType="pmc">PMC9090120</ArticleId><ArticleId IdType="pubmed">35571151</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y., Yang N., Gu X., Wang Y., Zhang H., Jia K. Risk Prediction Model of Early-Onset Preeclampsia Based on Risk Factors and Routine Laboratory Indicators. Life. 2023;13:1648. doi: 10.3390/life13081648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13081648</ArticleId><ArticleId IdType="pmc">PMC10455518</ArticleId><ArticleId IdType="pubmed">37629504</ArticleId></ArticleIdList></Reference><Reference><Citation>Elawad T., Scott G., Bone J.N., Elwell H., Lopez C.E., Filippi V., Green M., Khalil A., Kinshella M.W., Mistry H.D., et al. Risk factors for pre-eclampsia in clinical practice guidelines: Comparison with the evidence. BJOG. 2024;131:46&#x2013;62. doi: 10.1111/1471-0528.17320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.17320</ArticleId><ArticleId IdType="pubmed">36209504</ArticleId></ArticleIdList></Reference><Reference><Citation>Todros T., Verdiglione P., Ogg&#xe8; G., Paladini D., Vergani P., Cardaropoli S. Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection. Br. J. Clin. Pharmacol. 2006;61:336&#x2013;340. doi: 10.1111/j.1365-2125.2005.02572.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2005.02572.x</ArticleId><ArticleId IdType="pmc">PMC1885027</ArticleId><ArticleId IdType="pubmed">16487228</ArticleId></ArticleIdList></Reference><Reference><Citation>Todros T., Vasario E., Cardaropoli S. Preeclampsia as an infectious disease. Exp. Rev. Obs. Gynecol. 2007;2:735&#x2013;741. doi: 10.1586/17474108.2.6.735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17474108.2.6.735</ArticleId></ArticleIdList></Reference><Reference><Citation>Thagard P. How Scientists Explain Disease. Princeton University Press; Princeton, NJ, USA: 1999.</Citation></Reference><Reference><Citation>Thagard P. Coherence, truth, and the development of scientific knowledge. Philos. Sci. 2007;74:28&#x2013;47. doi: 10.1086/520941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520941</ArticleId></ArticleIdList></Reference><Reference><Citation>Thagard P., editor. The Cognitive Science of Science: Explanation, Discovery, and Conceptual Change. MIT Press; Cambridge, MA, USA: 2012.</Citation></Reference><Reference><Citation>Petsko G.A. Guilt by association. Genome Biol. 2009;10:104. doi: 10.1186/gb-2009-10-4-104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2009-10-4-104</ArticleId><ArticleId IdType="pmc">PMC2688918</ArticleId><ArticleId IdType="pubmed">19439034</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver S.G. Guilt-by-association goes global. Nature. 2000;403:601&#x2013;603. doi: 10.1038/35001165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35001165</ArticleId><ArticleId IdType="pubmed">10688178</ArticleId></ArticleIdList></Reference><Reference><Citation>Voy B.H., Scharff J.A., Perkins A.D., Saxton A.M., Borate B., Chesler E.J., Branstetter L.K., Langston M.A. Extracting gene networks for low-dose radiation using graph theoretical algorithms. PLoS Comput. Biol. 2006;2:e89. doi: 10.1371/journal.pcbi.0020089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.0020089</ArticleId><ArticleId IdType="pmc">PMC1513268</ArticleId><ArticleId IdType="pubmed">16854212</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian W., Zhang L.V., Tasan M., Gibbons F.D., King O.D., Park J., Wunderlich Z., Cherry J.M., Roth F.P. Combining guilt-by-association and guilt-by-profiling to predict Saccharomyces cerevisiae gene function. Genome Biol. 2008;9((Suppl. S1)):S7. doi: 10.1186/gb-2008-9-s1-s7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2008-9-s1-s7</ArticleId><ArticleId IdType="pmc">PMC2447541</ArticleId><ArticleId IdType="pubmed">18613951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillis J., Pavlidis P. &#x201c;Guilt by association&#x201d; is the exception rather than the rule in gene networks. PLoS Comput. Biol. 2012;8:e1002444. doi: 10.1371/journal.pcbi.1002444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1002444</ArticleId><ArticleId IdType="pmc">PMC3315453</ArticleId><ArticleId IdType="pubmed">22479173</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M. Genomics: The search for association. Nature. 2010;467:1135&#x2013;1138. doi: 10.1038/4671135a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4671135a</ArticleId><ArticleId IdType="pubmed">20981103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lappalainen T., Scott A.J., Brandt M., Hall I.M. Genomic Analysis in the Age of Human Genome Sequencing. Cell. 2019;177:70&#x2013;84. doi: 10.1016/j.cell.2019.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.02.032</ArticleId><ArticleId IdType="pmc">PMC6532068</ArticleId><ArticleId IdType="pubmed">30901550</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsheikh A.J., Wollenhaupt S., King E.A., Reeb J., Ghosh S., Stolzenburg L.R., Tamim S., Lazar J., Davis J.W., Jacob H.J. The landscape of GWAS validation; systematic review identifying 309 validated non-coding variants across 130 human diseases. BMC Med. Genom. 2022;15:74. doi: 10.1186/s12920-022-01216-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-022-01216-w</ArticleId><ArticleId IdType="pmc">PMC8973751</ArticleId><ArticleId IdType="pubmed">35365203</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the False Discovery Rate&#x2014;A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. B Met. 1995;57:289&#x2013;300. doi: 10.1111/j.2517-6161.1995.tb02031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadhurst D., Kell D.B. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics. 2006;2:171&#x2013;196. doi: 10.1007/s11306-006-0037-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-006-0037-z</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Oord E.J. Controlling false discoveries in genetic studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147B:637&#x2013;644. doi: 10.1002/ajmg.b.30650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.30650</ArticleId><ArticleId IdType="pubmed">18092307</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning M., Pavlidis P. &#x201c;Guilt by association&#x201d; is not competitive with genetic association for identifying autism risk genes. Sci. Rep. 2021;11:15950. doi: 10.1038/s41598-021-95321-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95321-y</ArticleId><ArticleId IdType="pmc">PMC8342445</ArticleId><ArticleId IdType="pubmed">34354131</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Falahi Z., Williamson J., Dimitri H. Atrial Fibrillation and Sleep Apnoea: Guilt by Association? Heart Lung Circ. 2017;26:902&#x2013;910. doi: 10.1016/j.hlc.2017.05.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2017.05.127</ArticleId><ArticleId IdType="pubmed">28652027</ArticleId></ArticleIdList></Reference><Reference><Citation>Bommasani R., Hudson D.A., Adeli E., Altman R., Arora S., Arx S.v., Bernstein M.S., Bohg J., Bosselut A., Brunskill E., et al. On the Opportunities and Risks of Foundation Models. arXiv. 20212108.07258</Citation></Reference><Reference><Citation>Vaswani A., Shazeer N., Parmar N., Uszkoreit J., Jones L., Gomez A.N., Kaiser L., Polosukhin I. Attention Is All You Need. arXiv. 20171706.03762</Citation></Reference><Reference><Citation>Kollman J.M., Pandi L., Sawaya M.R., Riley M., Doolittle R.F. Crystal Structure of Human Fibrinogen. Biochemistry. 2009;48:3877&#x2013;3886. doi: 10.1021/bi802205g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi802205g</ArticleId><ArticleId IdType="pubmed">19296670</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel J.W. Fibrinogen and fibrin. Adv. Protein Chem. 2005;70:247&#x2013;299. doi: 10.1016/S0065-3233(05)70008-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3233(05)70008-5</ArticleId><ArticleId IdType="pubmed">15837518</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel J.W., Litvinov R.I. Fibrin Formation, Structure and Properties. Subcell. Biochem. 2017;82:405&#x2013;456. doi: 10.1007/978-3-319-49674-0_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-49674-0_13</ArticleId><ArticleId IdType="pmc">PMC5536120</ArticleId><ArticleId IdType="pubmed">28101869</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet J.P., Park D., Lesty C., Soria J., Soria C., Montalescot G., Weisel J.W. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: Dynamic and structural approaches by confocal microscopy. Arterioscler. Thromb. Vasc. Biol. 2000;20:1354&#x2013;1361. doi: 10.1161/01.ATV.20.5.1354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.20.5.1354</ArticleId><ArticleId IdType="pubmed">10807754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri S., Kojima K., Sode K. Review of glucose oxidases and glucose dehydrogenases: A bird&#x2019;s eye view of glucose sensing enzymes. J. Diabetes Sci. Technol. 2011;5:1068&#x2013;1076. doi: 10.1177/193229681100500507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/193229681100500507</ArticleId><ArticleId IdType="pmc">PMC3208862</ArticleId><ArticleId IdType="pubmed">22027299</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Sigley J., Pieters M., Helms C.C., Nagaswami C., Weisel J.W., Guthold M. Fibrin Fiber Stiffness Is Strongly Affected by Fiber Diameter, but Not by Fibrinogen Glycation. Biophys. J. 2016;110:1400&#x2013;1410. doi: 10.1016/j.bpj.2016.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.02.021</ArticleId><ArticleId IdType="pmc">PMC4816776</ArticleId><ArticleId IdType="pubmed">27028649</ArticleId></ArticleIdList></Reference><Reference><Citation>Belcher H.A., Guthold M., Hudson N.E. What is the diameter of a fibrin fiber? Res. Pract. Thromb. Haemost. 2023;7:100285. doi: 10.1016/j.rpth.2023.100285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rpth.2023.100285</ArticleId><ArticleId IdType="pmc">PMC10439396</ArticleId><ArticleId IdType="pubmed">37601015</ArticleId></ArticleIdList></Reference><Reference><Citation>Guthold M., Liu W., Stephens B., Lord S.T., Hantgan R.R., Erie D.A., Taylor R.M., Jr., Superfine R. Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3. Biophys. J. 2004;87:4226&#x2013;4236. doi: 10.1529/biophysj.104.042333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.104.042333</ArticleId><ArticleId IdType="pmc">PMC1304931</ArticleId><ArticleId IdType="pubmed">15465869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bronkhorst P., Briedenhann S., Smit E., Franz R.C. Comparisons of the fibrin networks during pregnancy, nonpregnancy and pregnancy during dysfibrinogenaemia using the scanning electron microscope. Blood Coagul. Fibrinolysis. 2009;20:12&#x2013;16. doi: 10.1097/MBC.0b013e328322b429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e328322b429</ArticleId><ArticleId IdType="pubmed">20527721</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Oberholzer H.M., van der Spuy W.J., Meiring J.H. The changed ultrastructure of fibrin networks during use of oral contraception and hormone replacement. J. Thromb. Thrombolysis. 2010;30:502&#x2013;506. doi: 10.1007/s11239-010-0502-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-010-0502-4</ArticleId><ArticleId IdType="pubmed">20640484</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Swanepoel A.C., Oberholzer H.M., van der Spuy W.J., Duim W., Wessels P.F. A descriptive investigation of the ultrastructure of fibrin networks in thrombo-embolic ischemic stroke. J. Thromb. Thrombolysis. 2011;31:507&#x2013;513. doi: 10.1007/s11239-010-0538-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-010-0538-5</ArticleId><ArticleId IdType="pubmed">21221717</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Steyn H., Engelbrecht M., Swanepoel A.C., Oberholzer H.M. Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients. Blood Coagul. Fibrinolysis. 2011;22:696&#x2013;700. doi: 10.1097/MBC.0b013e32834bdb32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e32834bdb32</ArticleId><ArticleId IdType="pubmed">22001525</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E. The use of a desktop scanning electron microscope as a diagnostic tool in studying fibrin networks of thrombo-embolic ischemic stroke. Ultrastruct. Pathol. 2011;35:245&#x2013;250. doi: 10.3109/01913123.2011.606659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913123.2011.606659</ArticleId><ArticleId IdType="pubmed">21932989</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Oberholzer H.M., van der Spuy W.J., Swanepoel A.C., Soma P. Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes. Blood Coagul. Fibrinolysis. 2011;22:463&#x2013;467. doi: 10.1097/MBC.0b013e3283468a0d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e3283468a0d</ArticleId><ArticleId IdType="pubmed">21467917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski B., Pretorius E. Novel pathway of iron-induced blood coagulation: Implications for diabetes mellitus and its complications. Pol. Arch. Med. Wewn. 2012;122:115&#x2013;122. doi: 10.20452/pamw.1201.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.1201</ArticleId><ArticleId IdType="pubmed">22460041</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen) Integr. Biol. 2015;7:24&#x2013;52. doi: 10.1039/c4ib00173g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4ib00173g</ArticleId><ArticleId IdType="pubmed">25335120</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vermeulen N., Bester J., Lipinski B., Kell D.B. A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: The use of scanning electron microscopy. Toxicol. Mech. Methods. 2013;23:352&#x2013;359. doi: 10.3109/15376516.2012.762082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15376516.2012.762082</ArticleId><ArticleId IdType="pubmed">23278212</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Kell D.B. Diagnostic morphology: Biophysical indicators for iron-driven inflammatory diseases. Integr. Biol. 2014;6:486&#x2013;510. doi: 10.1039/C4IB00025K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4IB00025K</ArticleId><ArticleId IdType="pubmed">24714688</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bester J., Kell D.B. A bacterial component to Alzheimer-type dementia seen via a systems biology approach that links iron dysregulation and inflammagen shedding to disease. J. Alzheimers Dis. 2016;53:1237&#x2013;1256. doi: 10.3233/JAD-160318.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160318</ArticleId><ArticleId IdType="pmc">PMC5325058</ArticleId><ArticleId IdType="pubmed">27340854</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. No effects without causes. The Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases. Biol. Rev. 2018;93:1518&#x2013;1557. doi: 10.1111/brv.12407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12407</ArticleId><ArticleId IdType="pmc">PMC6055827</ArticleId><ArticleId IdType="pubmed">29575574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Heyden E.L., Pretorius E. The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria. Front. Immunol. 2020;11:1221. doi: 10.3389/fimmu.2020.01221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01221</ArticleId><ArticleId IdType="pmc">PMC7271924</ArticleId><ArticleId IdType="pubmed">32574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski B., Pretorius E., Oberholzer H.M., van der Spuy W.J. Interaction of fibrin with red blood cells: The role of iron. Ultrastruct. Pathol. 2012;36:79&#x2013;84. doi: 10.3109/01913123.2011.627491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913123.2011.627491</ArticleId><ArticleId IdType="pubmed">22471429</ArticleId></ArticleIdList></Reference><Reference><Citation>Crystal A.S., Giasson B.I., Crowe A., Kung M.P., Zhuang Z.P., Trojanowski J.Q., Lee V.M. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114. J. Neurochem. 2003;86:1359&#x2013;1368. doi: 10.1046/j.1471-4159.2003.01949.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01949.x</ArticleId><ArticleId IdType="pubmed">12950445</ArticleId></ArticleIdList></Reference><Reference><Citation>Palladini G., Merlini G. Systemic amyloidoses: What an internist should know. Eur. J. Intern. Med. 2013;24:729&#x2013;739. doi: 10.1016/j.ejim.2013.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2013.10.007</ArticleId><ArticleId IdType="pubmed">24262289</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Naharro A., Hawkins P.N., Fontana M. Cardiac amyloidosis. Clin. Med. 2018;18:s30&#x2013;s35. doi: 10.7861/clinmedicine.18-2-s30.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.18-2-s30</ArticleId><ArticleId IdType="pmc">PMC6334035</ArticleId><ArticleId IdType="pubmed">29700090</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagihi M.H.A., Bhattacharjee S. Amyloid Fibrillation of Insulin: Amelioration Strategies and Implications for Translation. ACS Pharmacol. Transl. Sci. 2022;5:1050&#x2013;1061. doi: 10.1021/acsptsci.2c00174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.2c00174</ArticleId><ArticleId IdType="pmc">PMC9667547</ArticleId><ArticleId IdType="pubmed">36407954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C.T., Chen Y.L., Hsu W.T., How S.C., Cheng Y.H., Hsueh S.S., Liu H.S., Lin T.H., Wu J.W., Wang S.S. Investigating the effects of erythrosine B on amyloid fibril formation derived from lysozyme. Int. J. Biol. Macromol. 2017;98:159&#x2013;168. doi: 10.1016/j.ijbiomac.2017.01.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2017.01.110</ArticleId><ArticleId IdType="pubmed">28137461</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A., Lakkaraju A.K.K. Cell Biology of Prions and Prionoids: A Status Report. Trends Cell Biol. 2016;26:40&#x2013;51. doi: 10.1016/j.tcb.2015.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.08.007</ArticleId><ArticleId IdType="pubmed">26455408</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A., De Cecco E. Shifts and drifts in prion science. Science. 2020;370:32&#x2013;34. doi: 10.1126/science.abb8577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8577</ArticleId><ArticleId IdType="pubmed">33004500</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontzek K., Bardelli M., Senatore A., Henzi A., Reimann R.R., Bedir S., Marino M., Hussain R., Jurt S., Meisl G., et al. A conformational switch controlling the toxicity of the prion protein. Nat. Struct. Mol. Biol. 2022;29:831&#x2013;840. doi: 10.1038/s41594-022-00814-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-022-00814-7</ArticleId><ArticleId IdType="pmc">PMC9371974</ArticleId><ArticleId IdType="pubmed">35948768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Mbotwe S., Kell D.B. Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular comorbidities. Sci. Rep. 2017;7:9680. doi: 10.1038/s41598-017-09860-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09860-4</ArticleId><ArticleId IdType="pmc">PMC5574907</ArticleId><ArticleId IdType="pubmed">28851981</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Engelbrecht L., Ellis G.C., Kell D.B. Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains. Cardiovasc. Diabetol. 2017;16:141. doi: 10.1186/s12933-017-0624-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-017-0624-5</ArticleId><ArticleId IdType="pmc">PMC5668975</ArticleId><ArticleId IdType="pubmed">29096623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bester J., Page M.J., Kell D.B. Reversal of amyloid formation in the plasma fibrin of individuals with Alzheimer-type dementia using LPS-binding protein. J. Alzheimers Dis. 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6113936</ArticleId><ArticleId IdType="pubmed">30186156</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B. Prevalence of readily detected amyloid blood clots in &#x2018;unclotted&#x2019; Type 2 Diabetes Mellitus and COVID-19 plasma: A preliminary report. Cardiovasc. Diabetol. 2020;19:193. doi: 10.1186/s12933-020-01165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Laubscher G.J., Khan M.A., Kell D.B., Pretorius E. Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model. Heliyon. 2023;9:e19605. doi: 10.1016/j.heliyon.2023.e19605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e19605</ArticleId><ArticleId IdType="pmc">PMC10558872</ArticleId><ArticleId IdType="pubmed">37809592</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubscher G.J., Lourens P.J., Venter C., Kell D.B., Pretorius E. TEG&#xae;, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. J. Clin. Med. 2021;10:5381. doi: 10.3390/jcm10225381.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225381</ArticleId><ArticleId IdType="pmc">PMC8621180</ArticleId><ArticleId IdType="pubmed">34830660</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamolodchikov D., Strickland S. Abeta delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin. Blood. 2012;119:3342&#x2013;3351. doi: 10.1182/blood-2011-11-389668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-11-389668</ArticleId><ArticleId IdType="pmc">PMC3321860</ArticleId><ArticleId IdType="pubmed">22238323</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Gianoulis T.A., Yip K.Y., Gerstein M., Snyder M. Extensive in vivo metabolite-protein interactions revealed by large-scale systematic analyses. Cell. 2010;143:639&#x2013;650. doi: 10.1016/j.cell.2010.09.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.09.048</ArticleId><ArticleId IdType="pmc">PMC3005334</ArticleId><ArticleId IdType="pubmed">21035178</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Snyder M. Metabolites as global regulators: A new view of protein regulation: Systematic investigation of metabolite-protein interactions may help bridge the gap between genome-wide association studies and small molecule screening studies. Bioessays. 2011;33:485&#x2013;489. doi: 10.1002/bies.201100026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201100026</ArticleId><ArticleId IdType="pubmed">21495048</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B. Metabolites do social networking. Nat. Chem. Biol. 2011;7:7&#x2013;8. doi: 10.1038/nchembio.505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.505</ArticleId><ArticleId IdType="pubmed">21164512</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanepoel A.C., Lindeque B.G., Swart P.J., Abdool Z., Pretorius E. Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: A qualitative investigation. Microsc. Res. Technol. 2014;77:594&#x2013;601. doi: 10.1002/jemt.22378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.22378</ArticleId><ArticleId IdType="pubmed">24841871</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanepoel A.C., Visagie A., de Lange Z., Emmerson O., Nielsen V.G., Pretorius E. The clinical relevance of altered fibrinogen packaging in the presence of 17beta-estradiol and progesterone. Thromb. Res. 2016;146:23&#x2013;34. doi: 10.1016/j.thromres.2016.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.08.022</ArticleId><ArticleId IdType="pubmed">27566845</ArticleId></ArticleIdList></Reference><Reference><Citation>Undas A. Fibrin clot properties and their modulation in thrombotic disorders. Thromb. Haemost. 2014;112:32&#x2013;42. doi: 10.1160/TH14-01-0032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH14-01-0032</ArticleId><ArticleId IdType="pubmed">24671700</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr M.E., Jr., Alving B.M. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul. Fibrinolysis. 1995;6:567&#x2013;573. doi: 10.1097/00001721-199509000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-199509000-00011</ArticleId><ArticleId IdType="pubmed">7578900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryk A.H., Natorska J., Zabczyk M., Zettl K., Wi&#x15b;niewski J.R., Undas A. Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties. J. Proteom. 2020;229:103946. doi: 10.1016/j.jprot.2020.103946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2020.103946</ArticleId><ArticleId IdType="pubmed">32810596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, long COVID and ME/CFS: Evidence, mechanisms, and therapeutic implications. Biochem. J. 2022;479:1653&#x2013;1708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B., Charlton B.T., Goulding R.P., Kerkhoff T.J., Breedveld E.A., Noort W., Offringa C., Bloemers F.W., van Weeghel M., Schomakers B.V., et al. Muscle abnormalities worsen after postexertional malaise in long COVID. Nat. Commun. 2024;15:17. doi: 10.1038/s41467-023-44432-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Johnsen S.P., Guo Y., Lip G.Y.H. Epidemiology of Atrial Fibrillation: Geographic/Ecological Risk Factors, Age, Sex, Genetics. Card. Electrophysiol. Clin. 2021;13:1&#x2013;23. doi: 10.1016/j.ccep.2020.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccep.2020.10.010</ArticleId><ArticleId IdType="pubmed">33516388</ArticleId></ArticleIdList></Reference><Reference><Citation>Essien U.R., Chiswell K., Kaltenbach L.A., Wang T.Y., Fonarow G.C., Thomas K.L., Turakhia M.P., Benjamin E.J., Rodriguez F., Fang M.C., et al. Association of Race and Ethnicity with Oral Anticoagulation and Associated Outcomes in Patients with Atrial Fibrillation: Findings from the Get with the Guidelines-Atrial Fibrillation Registry. JAMA Cardiol. 2022;7:1207&#x2013;1217. doi: 10.1001/jamacardio.2022.3704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2022.3704</ArticleId><ArticleId IdType="pmc">PMC9608025</ArticleId><ArticleId IdType="pubmed">36287545</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinigh R., Lip G.Y., Fiotti N., Giansante C., Lane D.A. Age as a risk factor for stroke in atrial fibrillation patients: Implications for thromboprophylaxis. J. Am. Coll. Cardiol. 2010;56:827&#x2013;837. doi: 10.1016/j.jacc.2010.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.05.028</ArticleId><ArticleId IdType="pubmed">20813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowres N., Olivier J., Chao T.F., Chen S.A., Chen Y., Diederichsen A., Fitzmaurice D.A., Gomez-Doblas J.J., Harbison J., Healey J.S., et al. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: A multicountry patient-level meta-analysis of 141,220 screened individuals. PLoS Med. 2019;16:e1002903. doi: 10.1371/journal.pmed.1002903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002903</ArticleId><ArticleId IdType="pmc">PMC6760766</ArticleId><ArticleId IdType="pubmed">31553733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayinde H., Schweizer M.L., Crabb V., Ayinde A., Abugroun A., Hopson J. Age modifies the risk of atrial fibrillation among athletes: A systematic literature review and meta-analysis. Int. J. Cardiol. Heart Vasc. 2018;18:25&#x2013;29. doi: 10.1016/j.ijcha.2018.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2018.01.002</ArticleId><ArticleId IdType="pmc">PMC5854837</ArticleId><ArticleId IdType="pubmed">29556526</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudis C.A., Ntalas I.V., Ketikoglou D.G. Atrial Fibrillation in Athletes. Cardiol. Rev. 2015;23:247&#x2013;251. doi: 10.1097/CRD.0000000000000049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000049</ArticleId><ArticleId IdType="pubmed">25479068</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaac E., Cooper S.M., Jones S.A., Loubani M. Do age-associated changes of voltage-gated sodium channel isoforms expressed in the mammalian heart predispose the elderly to atrial fibrillation? World J. Cardiol. 2020;12:123&#x2013;135. doi: 10.4330/wjc.v12.i4.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.4330/wjc.v12.i4.123</ArticleId><ArticleId IdType="pmc">PMC7215965</ArticleId><ArticleId IdType="pubmed">32431783</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T.J., Parise H., Levy D., D&#x2019;Agostino R.B., Sr., Wolf P.A., Vasan R.S., Benjamin E.J. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471&#x2013;2477. doi: 10.1001/jama.292.20.2471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.292.20.2471</ArticleId><ArticleId IdType="pubmed">15562125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanahita N., Messerli F.H., Bangalore S., Gami A.S., Somers V.K., Steinberg J.S. Atrial fibrillation and obesity--results of a meta-analysis. Am. Heart J. 2008;155:310&#x2013;315. doi: 10.1016/j.ahj.2007.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2007.10.004</ArticleId><ArticleId IdType="pubmed">18215602</ArticleId></ArticleIdList></Reference><Reference><Citation>Overvad T.F., Rasmussen L.H., Skj&#xf8;th F., Overvad K., Lip G.Y.H., Larsen T.B. Body mass index and adverse events in patients with incident atrial fibrillation. Am. J. Med. 2013;126:640.e9&#x2013;640.e17. doi: 10.1016/j.amjmed.2012.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2012.11.024</ArticleId><ArticleId IdType="pubmed">23601271</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu R.K., Ezekowitz J., Andersson U., Alexander J.H., Granger C.B., Halvorsen S., Hanna M., Hijazi Z., Jansky P., Lopes R.D., et al. The &#x2018;obesity paradox&#x2019; in atrial fibrillation: Observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. Eur. Heart J. 2016;37:2869&#x2013;2878. doi: 10.1093/eurheartj/ehw124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw124</ArticleId><ArticleId IdType="pubmed">27071819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W., Wan R., Liu F., Hu J., Huang L., Li J., Hong K. Relation of Body Mass Index with Adverse Outcomes among Patients with Atrial Fibrillation: A Meta-Analysis and Systematic Review. J. Am. Heart Assoc. 2016;5:e004006. doi: 10.1161/JAHA.116.004006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.004006</ArticleId><ArticleId IdType="pmc">PMC5079045</ArticleId><ArticleId IdType="pubmed">27613773</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietti M., Guiducci E., Cheli P., Lip G.Y. Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials. Stroke. 2017;48:857&#x2013;866. doi: 10.1161/STROKEAHA.116.015984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.015984</ArticleId><ArticleId IdType="pubmed">28265017</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu R.K., Ezekowitz J.A., Hijazi Z., Westerbergh J., Aulin J., Alexander J.H., Granger C.B., Halvorsen S., Hanna M.S., Lopes R.D., et al. Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: Insights from the ARISTOTLE trial. Open Heart. 2018;5:e000908. doi: 10.1136/openhrt-2018-000908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2018-000908</ArticleId><ArticleId IdType="pmc">PMC6242013</ArticleId><ArticleId IdType="pubmed">30487982</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Guo L., Xiao K., Zhu W., Liu M., Wan R., Hong K. The obesity paradox for outcomes in atrial fibrillation: Evidence from an exposure-effect analysis of prospective studies. Obes. Rev. 2020;21:e12970. doi: 10.1111/obr.12970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12970</ArticleId><ArticleId IdType="pubmed">31849187</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchal G., Mahmood M., Lip G.Y.H. Revisiting the risks of incident atrial fibrillation: A narrative review. Part 2. Kardiol. Pol. 2019;77:515&#x2013;524. doi: 10.33963/KP.14846.</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/KP.14846</ArticleId><ArticleId IdType="pubmed">31125027</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietti M., Boriani G. Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant Drugs. Am. J. Cardiovasc. Drugs. 2020;20:125&#x2013;137. doi: 10.1007/s40256-019-00374-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40256-019-00374-0</ArticleId><ArticleId IdType="pubmed">31583532</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Reyes H., Lara-Vaca S., Ochoa-Guzm&#xe1;n A., Chiquete E., Registro Mexicano de Fibrilaci&#xf3;n Auricular Study Group Obesity Paradox and 12 Month Outcome in Patients with Atrial Fibrillation. Arch. Med. Res. 2021;52:233&#x2013;239. doi: 10.1016/j.arcmed.2020.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.10.015</ArticleId><ArticleId IdType="pubmed">33160753</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.G., Xie P.X., Alsheikh-Ali A.A., AlMahmeed W., Sulaiman K., Asaad N., Liu S.W., Zubaid M., Lip G.Y.H. The &#x201c;obesity paradox&#x201d; in patients with atrial fibrillation: Insights from the Gulf SAFE registry. Front. Cardiovasc. Med. 2022;9:1032633. doi: 10.3389/fcvm.2022.1032633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1032633</ArticleId><ArticleId IdType="pmc">PMC9748618</ArticleId><ArticleId IdType="pubmed">36531711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Huang N., Chen X., Jiang S., Zhang W., Hu W., Su J., Dai H., Gu P., Huang X., et al. Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China. Cardiovasc. Drugs Ther. 2023;37:715&#x2013;727. doi: 10.1007/s10557-022-07332-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-022-07332-0</ArticleId><ArticleId IdType="pubmed">35394582</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S.U., Duran C.A., Rahman H., Lekkala M., Saleem M.A., Kaluski E. A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea. Eur. Heart J. 2018;39:2291&#x2013;2297. doi: 10.1093/eurheartj/ehx597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx597</ArticleId><ArticleId IdType="pubmed">29069399</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjafield A.V., Ayas N.T., Eastwood P.R., Heinzer R., Ip M.S.M., Morrell M.J., Nunez C.M., Patel S.R., Penzel T., Pepin J.L., et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis. Lancet Respir. Med. 2019;7:687&#x2013;698. doi: 10.1016/S2213-2600(19)30198-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(19)30198-5</ArticleId><ArticleId IdType="pmc">PMC7007763</ArticleId><ArticleId IdType="pubmed">31300334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Ye K., Xiaokereti J., Ma M., Guo Y., Zhou X., Tang B. Histopathological substrate of the atrial myocardium in the progression of obstructive sleep apnoea-related atrial fibrillation. Sleep Breath. 2021;25:807&#x2013;818. doi: 10.1007/s11325-020-02128-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11325-020-02128-8</ArticleId><ArticleId IdType="pubmed">33411188</ArticleId></ArticleIdList></Reference><Reference><Citation>Feghaly J., Zakka P., London B., MacRae C.A., Refaat M.M. Genetics of Atrial Fibrillation. J. Am. Heart Assoc. 2018;7:e009884. doi: 10.1161/JAHA.118.009884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.009884</ArticleId><ArticleId IdType="pmc">PMC6474960</ArticleId><ArticleId IdType="pubmed">30371258</ArticleId></ArticleIdList></Reference><Reference><Citation>Christophersen I.E., Ravn L.S., Budtz-J&#xf8;rgensen E., Skytthe A., Hauns&#xf8; S., Svendsen J.H., Christensen K. Familial aggregation of atrial fibrillation: A study in Danish twins. Circ. Arrhythm. Electrophysiol. 2009;2:378&#x2013;383. doi: 10.1161/CIRCEP.108.786665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.108.786665</ArticleId><ArticleId IdType="pmc">PMC2760022</ArticleId><ArticleId IdType="pubmed">19808493</ArticleId></ArticleIdList></Reference><Reference><Citation>Christophersen I.E., Budtz-Jorgensen E., Olesen M.S., Haunso S., Christensen K., Svendsen J.H. Familial atrial fibrillation predicts increased risk of mortality: A study in Danish twins. Circ. Arrhythm. Electrophysiol. 2013;6:10&#x2013;15. doi: 10.1161/CIRCEP.112.971580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.112.971580</ArticleId><ArticleId IdType="pubmed">23255276</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng L.C., Choi S.H., Klarin D., Smith J.G., Loh P.R., Chaffin M., Roselli C., Hulme O.L., Lunetta K.L., Dupuis J., et al. Heritability of Atrial Fibrillation. Circ. Cardiovasc. Genet. 2017;10:e001838. doi: 10.1161/CIRCGENETICS.117.001838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.117.001838</ArticleId><ArticleId IdType="pmc">PMC5966046</ArticleId><ArticleId IdType="pubmed">29237688</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli C., Chaffin M.D., Weng L.C., Aeschbacher S., Ahlberg G., Albert C.M., Almgren P., Alonso A., Anderson C.D., Aragam K.G., et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat. Genet. 2018;50:1225&#x2013;1233. doi: 10.1038/s41588-018-0133-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0133-9</ArticleId><ArticleId IdType="pmc">PMC6136836</ArticleId><ArticleId IdType="pubmed">29892015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J.G.M. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest. 2010;137:263&#x2013;272. doi: 10.1378/chest.09-1584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-1584</ArticleId><ArticleId IdType="pubmed">19762550</ArticleId></ArticleIdList></Reference><Reference><Citation>Friberg L., Rosenqvist M., Lip G.Y.H. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study. Eur. Heart J. 2012;33:1500&#x2013;1510. doi: 10.1093/eurheartj/ehr488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr488</ArticleId><ArticleId IdType="pubmed">22246443</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Proietti M., Senoo K., Lip G.Y.H. Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. Int. J. Cardiol. 2015;191:172&#x2013;177. doi: 10.1016/j.ijcard.2015.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.05.011</ArticleId><ArticleId IdType="pubmed">25974193</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.G., Miyazawa K., Wolff A., Zubaid M., Alsheikh-Ali A.A., Sulaiman K., Lip G.Y.H. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry. Int. J. Cardiol. 2019;274:158&#x2013;162. doi: 10.1016/j.ijcard.2018.08.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2018.08.091</ArticleId><ArticleId IdType="pubmed">30291008</ArticleId></ArticleIdList></Reference><Reference><Citation>Djouss&#xe9; L., Levy D., Benjamin E.J., Blease S.J., Russ A., Larson M.G., Massaro J.M., D&#x2019;Agostino R.B., Wolf P.A., Ellison R.C. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am. J. Cardiol. 2004;93:710&#x2013;713. doi: 10.1016/j.amjcard.2003.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2003.12.004</ArticleId><ArticleId IdType="pubmed">15019874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal K.J., Tolstrup J.S., Friberg J., Jensen G., Gronbaek M. Alcohol consumption and risk of atrial fibrillation in men and women: The Copenhagen City Heart Study. Circulation. 2005;112:1736&#x2013;1742. doi: 10.1161/CIRCULATIONAHA.105.547844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.547844</ArticleId><ArticleId IdType="pubmed">16157768</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers S.K., Deminice R., Ozdemir M., Yoshihara T., Bomkamp M.P., Hyatt H. Exercise-induced oxidative stress: Friend or foe? J. Sport. Health Sci. 2020;9:415&#x2013;425. doi: 10.1016/j.jshs.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jshs.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7498668</ArticleId><ArticleId IdType="pubmed">32380253</ArticleId></ArticleIdList></Reference><Reference><Citation>Thirupathi A., Pinho R.A., Ugbolue U.C., He Y., Meng Y., Gu Y. Effect of Running Exercise on Oxidative Stress Biomarkers: A Systematic Review. Front. Physiol. 2020;11:610112. doi: 10.3389/fphys.2020.610112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.610112</ArticleId><ArticleId IdType="pmc">PMC7854914</ArticleId><ArticleId IdType="pubmed">33551836</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira E., Marinho D.A., Neiva H.P., Lourenco O. Inflammatory Effects of High and Moderate Intensity Exercise-A Systematic Review. Front. Physiol. 2019;10:1550. doi: 10.3389/fphys.2019.01550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.01550</ArticleId><ArticleId IdType="pmc">PMC6962351</ArticleId><ArticleId IdType="pubmed">31992987</ArticleId></ArticleIdList></Reference><Reference><Citation>da Rocha A.L., Pinto A.P., Kohama E.B., Pauli J.R., de Moura L.P., Cintra D.E., Ropelle E.R., da Silva A.S.R. The proinflammatory effects of chronic excessive exercise. Cytokine. 2019;119:57&#x2013;61. doi: 10.1016/j.cyto.2019.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2019.02.016</ArticleId><ArticleId IdType="pubmed">30884427</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand F., Raberin A. Exercise-Induced Hypoxemia in Endurance Athletes: Consequences for Altitude Exposure. Front. Sports Act. Living. 2021;3:663674. doi: 10.3389/fspor.2021.663674.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fspor.2021.663674</ArticleId><ArticleId IdType="pmc">PMC8107360</ArticleId><ArticleId IdType="pubmed">33981992</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizer A., Gaziano J.M., Cook N.R., Manson J.E., Buring J.E., Albert C.M. Relation of vigorous exercise to risk of atrial fibrillation. Am. J. Cardiol. 2009;103:1572&#x2013;1577. doi: 10.1016/j.amjcard.2009.01.374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2009.01.374</ArticleId><ArticleId IdType="pmc">PMC2687527</ArticleId><ArticleId IdType="pubmed">19463518</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi W.T., Alirhayim Z., Blaha M.J., Juraschek S.P., Keteyian S.J., Brawner C.A., Al-Mallah M.H. Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results from the Henry Ford Exercise Testing (FIT) Project. Circulation. 2015;131:1827&#x2013;1834. doi: 10.1161/CIRCULATIONAHA.114.014833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.014833</ArticleId><ArticleId IdType="pubmed">25904645</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaszczyk R.T., Gorlo A., Dukacz M., Konopka A., Glowniak A. Association between exposure to air pollution and incidence of atrial fibrillation. Ann. Agric. Environ. Med. 2023;30:15&#x2013;21. doi: 10.26444/aaem/157189.</Citation><ArticleIdList><ArticleId IdType="doi">10.26444/aaem/157189</ArticleId><ArticleId IdType="pubmed">36999851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandaglio-Collados D., L&#xf3;pez-G&#xe1;lvez R., Ruiz-Alcaraz A.J., L&#xf3;pez-Garc&#xed;a C., Rold&#xe1;n V., Lip G.Y.H., Mar&#xed;n F., Rivera-Caravaca J.M. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review. Sci. Total Environ. 2023;880:163352. doi: 10.1016/j.scitotenv.2023.163352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2023.163352</ArticleId><ArticleId IdType="pubmed">37023806</ArticleId></ArticleIdList></Reference><Reference><Citation>Link M.S., Luttmann-Gibson H., Schwartz J., Mittleman M.A., Wessler B., Gold D.R., Dockery D.W., Laden F. Acute exposure to air pollution triggers atrial fibrillation. J. Am. Coll. Cardiol. 2013;62:816&#x2013;825. doi: 10.1016/j.jacc.2013.05.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.05.043</ArticleId><ArticleId IdType="pmc">PMC3752319</ArticleId><ArticleId IdType="pubmed">23770178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Chen G., Xia H., Wang X., Wang C., Cai M., Gao Y., Lip G.Y.H., Lin H. Associations of Life&#x2019;s Essential 8 and fine particulate matter pollution with the incidence of atrial fibrillation. J. Hazard. Mater. 2023;459:132114. doi: 10.1016/j.jhazmat.2023.132114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhazmat.2023.132114</ArticleId><ArticleId IdType="pubmed">37494795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Su B., Li D., Cui F., Tang L., Wang J., Tian Y., Zheng X. Air pollution, genetic susceptibility, and the risk of atrial fibrillation: A large prospective cohort study. Proc. Natl. Acad. Sci. USA. 2023;120:e2302708120. doi: 10.1073/pnas.2302708120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2302708120</ArticleId><ArticleId IdType="pmc">PMC10410743</ArticleId><ArticleId IdType="pubmed">37523535</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Ahat X., Liang Q., Ma Y., Sun M., Lin L., Li T., Duan J., Sun Z. The relationship between exposure to PM2.5 and atrial fibrillation in older adults: A systematic review and meta-analysis. Sci. Total Environ. 2021;784:147106. doi: 10.1016/j.scitotenv.2021.147106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2021.147106</ArticleId><ArticleId IdType="pubmed">34088062</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q., Liu T., Korantzopoulos P., Zhang Z., Zhao J., Li G. Association between air pollution and development of atrial fibrillation: A meta-analysis of observational studies. Heart Lung. 2016;45:557&#x2013;562. doi: 10.1016/j.hrtlng.2016.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2016.08.001</ArticleId><ArticleId IdType="pubmed">27590407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue C., Yang F., Li F., Chen Y. Association between air pollutants and atrial fibrillation in general population: A systematic review and meta-analysis. Ecotoxicol. Environ. Saf. 2021;208:111508. doi: 10.1016/j.ecoenv.2020.111508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecoenv.2020.111508</ArticleId><ArticleId IdType="pubmed">33142159</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L., Solt A.C., Henriquez-Rold&#xe1;n C., Torres-Jardon R., Nuse B., Herritt L., Villarreal-Calder&#xf3;n R., Osnaya N., Stone I., Garcia R., et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol. Pathol. 2008;36:289&#x2013;310. doi: 10.1177/0192623307313011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0192623307313011</ArticleId><ArticleId IdType="pubmed">18349428</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaccarino L., La Joie R., Lesman-Segev O.H., Lee E., Hanna L., Allen I.E., Hillner B.E., Siegel B.A., Whitmer R.A., Carrillo M.C., et al. Association between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults with Cognitive Impairment. JAMA Neurol. 2021;78:197&#x2013;207. doi: 10.1001/jamaneurol.2020.3962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.3962</ArticleId><ArticleId IdType="pmc">PMC7879238</ArticleId><ArticleId IdType="pubmed">33252608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S., Kim E.W., Zhang Y., Lee J., Cho S.Y., Ha J., Kim H., Kim E. Particulate matter increases beta-amyloid and activated glial cells in hippocampal tissues of transgenic Alzheimer&#x2019;s mouse: Involvement of PARP-1. Biochem. Biophys. Res. Commun. 2018;500:333&#x2013;338. doi: 10.1016/j.bbrc.2018.04.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.04.068</ArticleId><ArticleId IdType="pubmed">29654761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu B., Mackos A.R., Floden A.M., Wold L.E., Combs C.K. Particulate Matter Exposure Exacerbates Amyloid-beta Plaque Deposition and Gliosis in APP/PS1 Mice. J. Alzheimers Dis. 2021;80:761&#x2013;774. doi: 10.3233/JAD-200919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200919</ArticleId><ArticleId IdType="pmc">PMC8100996</ArticleId><ArticleId IdType="pubmed">33554902</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfella R., Prattichizzo F., Sardu C., Fulgenzi G., Graciotti L., Spadoni T., D&#x2019;Onofrio N., Scisciola L., La Grotta R., Frig&#xe9; C., et al. Microplastics and nanoplastics in atheromas and cardiovascular events. N. Engl. J. Med. 2024;390:900&#x2013;910. doi: 10.1056/NEJMoa2309822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2309822</ArticleId><ArticleId IdType="pmc">PMC11009876</ArticleId><ArticleId IdType="pubmed">38446676</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaker E.D., Sullivan L.M., Kelly-Hayes M., D&#x2019;Agostino R.B., Sr., Benjamin E.J. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation. 2004;109:1267&#x2013;1271. doi: 10.1161/01.CIR.0000118535.15205.8F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000118535.15205.8F</ArticleId><ArticleId IdType="pubmed">14993133</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchal G., Mahmood M., Lip G.Y.H. Revisiting the risks of incident atrial fibrillation: A narrative review. Part 1. Kardiol. Pol. 2019;77:430&#x2013;436. doi: 10.33963/KP.14806.</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/KP.14806</ArticleId><ArticleId IdType="pubmed">31025653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B. Iron behaving badly: Inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genom. 2009;2:2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2672098</ArticleId><ArticleId IdType="pubmed">19133145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson&#x2019;s, Huntington&#x2019;s, Alzheimer&#x2019;s, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 2010;577:825&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988997</ArticleId><ArticleId IdType="pubmed">20967426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Serum ferritin is an important disease marker, and is mainly a leakage product from damaged cells. Metallomics. 2014;6:748&#x2013;773. doi: 10.1039/C3MT00347G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C3MT00347G</ArticleId><ArticleId IdType="pubmed">24549403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Heyden E.L., Pretorius E. The biology of lactoferrin, an iron-binding protein that defends against viruses and bacteria.  [(accessed on 1 March 2024)];OSF Prepr. 2020  doi: 10.3389/fimmu.2020.01221. Available online:  https://osf.io/fxudj/</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01221</ArticleId><ArticleId IdType="pmc">PMC7271924</ArticleId><ArticleId IdType="pubmed">32574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki R.F., Cosby S.L., Wozniak M.A. Herpes simplex virus type 1 and Alzheimer&#x2019;s disease: The autophagy connection. J. Neurovirol. 2008;14:1&#x2013;4. doi: 10.1080/13550280701802543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280701802543</ArticleId><ArticleId IdType="pubmed">18300070</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki R.F., Lathe R., Balin B.J., Ball M.J., Braak H., Bearer E.L., Bullido M.J., Carter C., Clerici M., Cosby S.L., et al. Microbes and Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2016;51:979&#x2013;984. doi: 10.3233/JAD-160152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160152</ArticleId><ArticleId IdType="pmc">PMC5457904</ArticleId><ArticleId IdType="pubmed">26967229</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki R.F., Lathe R. Herpes Viruses and Senile Dementia: First Population Evidence for a Causal Link. J. Alzheimers Dis. 2018;64:363&#x2013;366. doi: 10.3233/JAD-180266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180266</ArticleId><ArticleId IdType="pubmed">29889070</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki R.F. Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2018;10:324. doi: 10.3389/fnagi.2018.00324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00324</ArticleId><ArticleId IdType="pmc">PMC6202583</ArticleId><ArticleId IdType="pubmed">30405395</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C., van Tongeren M., Gettemans J., Kell D., Pretorius E. Alzheimer-type dementia: A systems view provides a unifying explanation of its development. J. Alzheimer&#x2019;s Dis. 2023;91:43&#x2013;70. doi: 10.3233/JAD-220720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220720</ArticleId><ArticleId IdType="pubmed">36442193</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean-Baptiste V.S.E., Xia C.Q., Clare-Salzler M.J., Horwitz M.S. Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas. EBioMedicine. 2017;22:10&#x2013;17. doi: 10.1016/j.ebiom.2017.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.06.014</ArticleId><ArticleId IdType="pmc">PMC5552106</ArticleId><ArticleId IdType="pubmed">28663145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundersen E. Is Diabetes of Infectious Origin? J. Infect. Dis. 1927;41:197&#x2013;202. doi: 10.1093/infdis/41.3.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/41.3.197</ArticleId></ArticleIdList></Reference><Reference><Citation>Craighead J.E. The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus. Prog. Med. Virol. 1975;19:161&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">164049</ArticleId></ArticleIdList></Reference><Reference><Citation>Notkins A.L. Virus-induced diabetes mellitus. Arch. Virol. 1977;54:1&#x2013;17. doi: 10.1007/BF01314374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01314374</ArticleId><ArticleId IdType="pubmed">196570</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon J.W., Notkins A.L. Virus-induced diabetes in mice. Metabolism. 1983;32:37&#x2013;40. doi: 10.1016/S0026-0495(83)80009-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0026-0495(83)80009-2</ArticleId><ArticleId IdType="pubmed">6306392</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajsfus B.F., Mohana-Borges R., Allonso D. Diabetogenic viruses: Linking viruses to diabetes mellitus. Heliyon. 2023;9:e15021. doi: 10.1016/j.heliyon.2023.e15021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e15021</ArticleId><ArticleId IdType="pmc">PMC10102442</ArticleId><ArticleId IdType="pubmed">37064445</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bester J., Vermeulen N., Alummoottil S., Soma P., Buys A.V., Kell D.B. Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: Implications for diagnostics. Cardiovasc. Diabetol. 2015;13:30. doi: 10.1186/s12933-015-0192-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0192-5</ArticleId><ArticleId IdType="pmc">PMC4364097</ArticleId><ArticleId IdType="pubmed">25848817</ArticleId></ArticleIdList></Reference><Reference><Citation>Soma P., Pretorius E. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus. Cardiovasc. Diabetol. 2015;14:96. doi: 10.1186/s12933-015-0261-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0261-9</ArticleId><ArticleId IdType="pmc">PMC4521497</ArticleId><ArticleId IdType="pubmed">26228646</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayakrishnan B. Historical aspects and current understanding of the connections and implications of viruses and diabetes: A narrative review. Clin. Epidemiol. Glob. Health. 2022;16:101110. doi: 10.1016/j.cegh.2022.101110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2022.101110</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohail M.U., Mashood F., Oberbach A., Chennakkandathil S., Schmidt F. The role of pathogens in diabetes pathogenesis and the potential of immunoproteomics as a diagnostic and prognostic tool. Front. Microbiol. 2022;13:1042362. doi: 10.3389/fmicb.2022.1042362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1042362</ArticleId><ArticleId IdType="pmc">PMC9724628</ArticleId><ArticleId IdType="pubmed">36483212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobs S.P., Kolodziejczyk A.A., Adler L., Horesh N., Botscharnikow C., Herzog E., Mohapatra G., Hejndorf S., Hodgetts R.J., Spivak I., et al. Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes. Nature. 2023;624:645&#x2013;652. doi: 10.1038/s41586-023-06803-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06803-0</ArticleId><ArticleId IdType="pmc">PMC10733144</ArticleId><ArticleId IdType="pubmed">38093014</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed Z., Velasquez Garcia H.A., Wong S., Wilton J., McKee G., Mahmood B., Binka M., Rasali D., Janjua N.Z. Association of COVID-19 Infection with Incident Diabetes. JAMA Netw. Open. 2023;6:e238866. doi: 10.1001/jamanetworkopen.2023.8866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.8866</ArticleId><ArticleId IdType="pmc">PMC10114057</ArticleId><ArticleId IdType="pubmed">37071420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wekerle H. Epstein-Barr virus sparks brain autoimmunity in multiple sclerosis. Nature. 2022;603:230&#x2013;232. doi: 10.1038/d41586-022-00382-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00382-2</ArticleId><ArticleId IdType="pubmed">35169323</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nrich G., Abdelaziz M.O., Raftery M.J. Epstein-Barr virus, interleukin-10 and multiple sclerosis: A m&#xe9;nage &#xe0; trois. Front. Immunol. 2022;13:1028972. doi: 10.3389/fimmu.2022.1028972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1028972</ArticleId><ArticleId IdType="pmc">PMC9585213</ArticleId><ArticleId IdType="pubmed">36275700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau B.A., Bhaduri-McIntosh S. Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection. Viruses. 2023;15:949. doi: 10.3390/v15040949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040949</ArticleId><ArticleId IdType="pmc">PMC10141000</ArticleId><ArticleId IdType="pubmed">37112929</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kell D.B., Pretorius E. Cardiovascular and haematological pathology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A role for Viruses. Blood Rev. 2023;60:101075. doi: 10.1016/j.blre.2023.101075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2023.101075</ArticleId><ArticleId IdType="pmc">PMC10027292</ArticleId><ArticleId IdType="pubmed">36963989</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kruger A., Proal A., Kell D.B., Pretorius E. The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Pharmaceuticals. 2022;15:931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon T., Gruenheid S. Microbes and Parkinson&#x2019;s disease: From associations to mechanisms. Trends Microbiol. 2022;30:749&#x2013;760. doi: 10.1016/j.tim.2022.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2022.01.004</ArticleId><ArticleId IdType="pubmed">35144890</ArticleId></ArticleIdList></Reference><Reference><Citation>Leta V., Urso D., Batzu L., Lau Y.H., Mathew D., Boura I., Raeder V., Falup-Pecurariu C., van Wamelen D., Ray Chaudhuri K. Viruses, parkinsonism and Parkinson&#x2019;s disease: The past, present and future. J. Neural Transm. 2022;129:1119&#x2013;1132. doi: 10.1007/s00702-022-02536-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-022-02536-y</ArticleId><ArticleId IdType="pmc">PMC9422946</ArticleId><ArticleId IdType="pubmed">36036863</ArticleId></ArticleIdList></Reference><Reference><Citation>Limphaibool N., Iwanowski P., Holstad M.J.V., Kobylarek D., Kozubski W. Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications. Front. Neurol. 2019;10:652. doi: 10.3389/fneur.2019.00652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00652</ArticleId><ArticleId IdType="pmc">PMC6593078</ArticleId><ArticleId IdType="pubmed">31275235</ArticleId></ArticleIdList></Reference><Reference><Citation>Caggiu E., Arru G., Hosseini S., Niegowska M., Sechi G., Zarbo I.R., Sechi L.A. Inflammation, Infectious Triggers, and Parkinson&#x2019;s Disease. Front. Neurol. 2019;10 doi: 10.3389/fneur.2019.00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00122</ArticleId><ArticleId IdType="pmc">PMC6389614</ArticleId><ArticleId IdType="pubmed">30837941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer A., Rashid T. Rheumatoid arthritis is caused by Proteus: The molecular mimicry theory and Karl Popper. Front. Biosci. 2009;1:577&#x2013;586. doi: 10.2741/e56.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/e56</ArticleId><ArticleId IdType="pubmed">19482674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer A., Rashid T., Wilson C. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmun. Rev. 2010;9:216&#x2013;223. doi: 10.1016/j.autrev.2009.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.10.006</ArticleId><ArticleId IdType="pubmed">19895906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer A. Rheumatoid Arthritis and Proteus. Springer; London, UK: 2012.</Citation></Reference><Reference><Citation>Ebringer A., Rashid T. Rheumatoid arthritis is caused by a Proteus urinary tract infection. APMIS. 2014;122:363&#x2013;368. doi: 10.1111/apm.12154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.12154</ArticleId><ArticleId IdType="pubmed">23992372</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezuidenhout J., Venter C., Roberts T., Tarr G., Kell D., Pretorius E. Detection of citrullinated fibrin in plasma clots of RA patients and its relation to altered structural clot properties, disease-related inflammation and prothrombotic tendency. Front. Immunol. 2020;11:577523. doi: 10.3389/fimmu.2020.577523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.577523</ArticleId><ArticleId IdType="pmc">PMC7793985</ArticleId><ArticleId IdType="pubmed">33424834</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Oberholzer H.M., van der Spuy W.J., Swanepoel A.C., Soma P. Scanning electron microscopy of fibrin networks in rheumatoid arthritis: A qualitative analysis. Rheumatol. Int. 2012;32:1611&#x2013;1615. doi: 10.1007/s00296-011-1805-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-1805-2</ArticleId><ArticleId IdType="pubmed">21331577</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Akeredolu O.-O., Soma P., Kell D.B. Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp. Biol. Med. 2017;242:355&#x2013;373. doi: 10.1177/1535370216681549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370216681549</ArticleId><ArticleId IdType="pmc">PMC5298544</ArticleId><ArticleId IdType="pubmed">27889698</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudis C.A., Ketikoglou D.G. Obstructive sleep and atrial fibrillation: Pathophysiological mechanisms and therapeutic implications. Int. J. Cardiol. 2017;230:293&#x2013;300. doi: 10.1016/j.ijcard.2016.12.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.12.120</ArticleId><ArticleId IdType="pubmed">28040290</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller M.A., Cappuccio F.P. A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med. Rev. 2021;55:101382. doi: 10.1016/j.smrv.2020.101382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2020.101382</ArticleId><ArticleId IdType="pmc">PMC7833740</ArticleId><ArticleId IdType="pubmed">32980614</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel H.L., Colleen G., Abedian S., Ammar N., Charles Bailey L., Bennett T.D., Daniel Brannock M., Brosnahan S.B., Chen Y., Chute C.G., et al. Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: An electronic health record-based analysis from the RECOVER initiative. Sleep. 2023;46:zsad126. doi: 10.1093/sleep/zsad126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/zsad126</ArticleId><ArticleId IdType="pmc">PMC10485569</ArticleId><ArticleId IdType="pubmed">37166330</ArticleId></ArticleIdList></Reference><Reference><Citation>Su V.Y., Liu C.J., Wang H.K., Wu L.A., Chang S.C., Perng D.W., Su W.J., Chen Y.M., Lin E.Y., Chen T.J., et al. Sleep apnea and risk of pneumonia: A nationwide population-based study. CMAJ. 2014;186:415&#x2013;421. doi: 10.1503/cmaj.131547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.131547</ArticleId><ArticleId IdType="pmc">PMC3971026</ArticleId><ArticleId IdType="pubmed">24591276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiner E., Llombart M., Valls J., Pastor E., Sancho-Chust J.N., Andreu A.L., Sanchez-de-la-Torre M., Barbe F. Association between Obstructive Sleep Apnea and Community-Acquired Pneumonia. PLoS ONE. 2016;11:e0152749. doi: 10.1371/journal.pone.0152749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152749</ArticleId><ArticleId IdType="pmc">PMC4822965</ArticleId><ArticleId IdType="pubmed">27050437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto T.I., Kurniawan A. Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis. Sleep Med. 2021;82:47&#x2013;53. doi: 10.1016/j.sleep.2021.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2021.03.029</ArticleId><ArticleId IdType="pmc">PMC8012298</ArticleId><ArticleId IdType="pubmed">33892451</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara M., Washida K. Linking Atrial Fibrillation with Alzheimer&#x2019;s Disease: Epidemiological, Pathological, and Mechanistic Evidence. J. Alzheimers Dis. 2018;62:61&#x2013;72. doi: 10.3233/JAD-170970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170970</ArticleId><ArticleId IdType="pmc">PMC5817903</ArticleId><ArticleId IdType="pubmed">29439352</ArticleId></ArticleIdList></Reference><Reference><Citation>Benenati S., Canale C., De Marzo V., Della Bona R., Rosa G.M., Porto I. Atrial fibrillation and Alzheimer&#x2019;s disease: A conundrum. Eur. J. Clin. Investig. 2021;51:e13451. doi: 10.1111/eci.13451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13451</ArticleId><ArticleId IdType="pubmed">33219514</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y., Wang Y., Wang Y. Investigation of Causal Effect of Atrial Fibrillation on Alzheimer Disease: A Mendelian Randomization Study. J. Am. Heart Assoc. 2020;9:e014889. doi: 10.1161/JAHA.119.014889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.014889</ArticleId><ArticleId IdType="pmc">PMC7033843</ArticleId><ArticleId IdType="pubmed">31914880</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietti R., AlTurki A., Vio R., Licchelli L., Rivezzi F., Marafi M., Russo V., Potpara T.S., Kalman J.M., de Villers-Sidani E., et al. The association between atrial fibrillation and Alzheimer&#x2019;s disease: Fact or fallacy? A systematic review and meta-analysis. J. Cardiovasc. Med. 2020;21:106&#x2013;112. doi: 10.2459/JCM.0000000000000917.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000000917</ArticleId><ArticleId IdType="pubmed">31815852</ArticleId></ArticleIdList></Reference><Reference><Citation>Papanastasiou C.A., Theochari C.A., Zareifopoulos N., Arfaras-Melainis A., Giannakoulas G., Karamitsos T.D., Palaiodimos L., Ntaios G., Avgerinos K.I., Kapogiannis D., et al. Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer&#x2019;s Disease: A Systematic Review and Meta-Analysis. J. Gen. Intern. Med. 2021;36:3122&#x2013;3135. doi: 10.1007/s11606-021-06954-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-06954-8</ArticleId><ArticleId IdType="pmc">PMC8481403</ArticleId><ArticleId IdType="pubmed">34244959</ArticleId></ArticleIdList></Reference><Reference><Citation>Manemann S.M., Chamberlain A.M., Bielinski S.J., Jiang R., Weston S.A., Roger V.L. Predicting Alzheimer&#x2019;s Disease and Related Dementias in Heart Failure and Atrial Fibrillation. Am. J. Med. 2023;136:302&#x2013;307. doi: 10.1016/j.amjmed.2022.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2022.11.010</ArticleId><ArticleId IdType="pmc">PMC9957820</ArticleId><ArticleId IdType="pubmed">36502953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakase T., Tatewaki Y., Thyreau B., Odagiri H., Tomita N., Yamamoto S., Takano Y., Muranaka M., Taki Y. Impact of atrial fibrillation on the cognitive decline in Alzheimer&#x2019;s disease. Alzheimers Res. Ther. 2023;15:15. doi: 10.1186/s13195-023-01165-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-023-01165-1</ArticleId><ArticleId IdType="pmc">PMC9838038</ArticleId><ArticleId IdType="pubmed">36635728</ArticleId></ArticleIdList></Reference><Reference><Citation>Falsetti L., Viticchi G., Buratti L., Grigioni F., Capucci A., Silvestrini M. Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer&#x2019;s Disease: A Prospective Cohort Study. J. Alzheimers Dis. 2018;62:713&#x2013;725. doi: 10.3233/JAD-170544.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170544</ArticleId><ArticleId IdType="pubmed">29480173</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Z., Liu T., Tse G., Gong M., Gladding P.A., Smaill B.H., Stiles M.K., Gillis A.M., Zhao J. A Machine Learning Aided Systematic Review and Meta-Analysis of the Relative Risk of Atrial Fibrillation in Patients with Diabetes Mellitus. Front. Physiol. 2018;9:835. doi: 10.3389/fphys.2018.00835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00835</ArticleId><ArticleId IdType="pmc">PMC6037848</ArticleId><ArticleId IdType="pubmed">30018571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A., Green J.B., Halperin J.L., Piccini J.P., Sr. Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2019;74:1107&#x2013;1115. doi: 10.1016/j.jacc.2019.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.07.020</ArticleId><ArticleId IdType="pubmed">31439220</ArticleId></ArticleIdList></Reference><Reference><Citation>Domek M., Li Y.G., Gumprecht J., Asaad N., Rashed W., Alsheikh-Ali A., Nabrdalik K., Gumprecht J., Zubaid M., Lip G.Y.H. One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry. Int. J. Cardiol. 2020;302:47&#x2013;52. doi: 10.1016/j.ijcard.2019.12.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2019.12.061</ArticleId><ArticleId IdType="pubmed">31948674</ArticleId></ArticleIdList></Reference><Reference><Citation>Alijla F., Buttia C., Reichlin T., Razvi S., Minder B., Wilhelm M., Muka T., Franco O.H., Bano A. Association of diabetes with atrial fibrillation types: A systematic review and meta-analysis. Cardiovasc. Diabetol. 2021;20:230. doi: 10.1186/s12933-021-01423-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01423-2</ArticleId><ArticleId IdType="pmc">PMC8653594</ArticleId><ArticleId IdType="pubmed">34876114</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J., Lee S.R., Choi E.K., Lee H., Han M., Ahn H.J., Kwon S., Lee S.W., Han K.D., Oh S., et al. Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: A nationwide population study. Cardiovasc. Diabetol. 2023;22:12. doi: 10.1186/s12933-023-01736-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-01736-4</ArticleId><ArticleId IdType="pmc">PMC9854085</ArticleId><ArticleId IdType="pubmed">36658574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon S., Lee S.R., Choi E.K., Ahn H.J., Lee S.W., Jung J.H., Han K.D., Oh S., Lip G.Y.H. Association between Atrial Fibrillation and Diabetes-Related Complications: A Nationwide Cohort Study. Diabetes Care. 2023;46:2240&#x2013;2248. doi: 10.2337/dc23-0931.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc23-0931</ArticleId><ArticleId IdType="pubmed">37851370</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding W.Y., Kotalczyk A., Boriani G., Marin F., Blomstr&#xf6;m-Lundqvist C., Potpara T.S., Fauchier L., Lip G.Y.H., ESC-EHRA EORP-AF Long-Term General Registry Investigators Impact of diabetes on the management and outcomes in atrial fibrillation: An analysis from the ESC-EHRA EORP-AF Long-Term General Registry. Eur. J. Intern. Med. 2022;103:41&#x2013;49. doi: 10.1016/j.ejim.2022.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2022.04.026</ArticleId><ArticleId IdType="pubmed">35527179</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo-Almor&#xf3;s A., Casado Cerrada J., &#xc1;lvarez-Sala Walther L.A., M&#xe9;ndez Bail&#xf3;n M., Lorenzo Gonz&#xe1;lez &#xd3;. Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders? J. Clin. Med. 2023;12:2868. doi: 10.3390/jcm12082868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12082868</ArticleId><ArticleId IdType="pmc">PMC10142815</ArticleId><ArticleId IdType="pubmed">37109205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohne L.J., Johnson D., Rose R.A., Wilton S.B., Gillis A.M. The Association between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights. Front. Physiol. 2019;10:135. doi: 10.3389/fphys.2019.00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00135</ArticleId><ArticleId IdType="pmc">PMC6399657</ArticleId><ArticleId IdType="pubmed">30863315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong C.T., Chan L., Wu D., Chen W.T., Chien L.N. Association between Parkinson&#x2019;s Disease and Atrial Fibrillation: A Population-Based Study. Front. Neurol. 2019;10:22. doi: 10.3389/fneur.2019.00022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00022</ArticleId><ArticleId IdType="pmc">PMC6370731</ArticleId><ArticleId IdType="pubmed">30804869</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves M., Abrantes A.M., Portugal G., Cruz M.M., Reimao S., Caldeira D., Ferro J.M., Ferreira J.J. Does Parkinson&#x2019;s Disease Increase the Risk of Atrial Fibrillation? Insights from Electrocardiogram and Risk Scores from a Case-Control Study. Front. Neurol. 2021;12:633900. doi: 10.3389/fneur.2021.633900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.633900</ArticleId><ArticleId IdType="pmc">PMC8149901</ArticleId><ArticleId IdType="pubmed">34054687</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S., Moon I., Choi E.K., Han K.D., Cho H.C., Lee S.Y., Yang S., Kwon S., Choi Y.J., Lee H.J., et al. Increased atrial fibrillation risk in Parkinson&#x2019;s disease: A nationwide population-based study. Ann. Clin. Transl. Neurol. 2021;8:238&#x2013;246. doi: 10.1002/acn3.51279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51279</ArticleId><ArticleId IdType="pmc">PMC7818085</ArticleId><ArticleId IdType="pubmed">33389803</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereja F., Alves M., Ferreira J.J., Caldeira D. Atrial fibrillation risk on Parkinson&#x2019;s disease&#x2014;A systematic review and meta-analysis. J. Thromb. Thrombolysis. 2023;55:747&#x2013;750. doi: 10.1007/s11239-023-02792-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-023-02792-z</ArticleId><ArticleId IdType="pubmed">36964284</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong J.C., Chen X.D., Jin N.K., Hong J. Exploring the causal association of rheumatoid arthritis with atrial fibrillation: A Mendelian randomization study. Clin. Rheumatol. 2023;43:29&#x2013;40. doi: 10.1007/s10067-023-06804-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-023-06804-4</ArticleId><ArticleId IdType="pubmed">37930596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.W., Han M., Jung I., Ahn S.S. New-onset atrial fibrillation in seropositive rheumatoid arthritis: Association with disease-modifying anti-rheumatic drugs treatment. Rheumatology. 2023;63:630&#x2013;638. doi: 10.1093/rheumatology/kead336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kead336</ArticleId><ArticleId IdType="pubmed">37421392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerola A.M., Rollefstad S., Semb A.G. Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment. Eur. Cardiol. 2021;16:e18. doi: 10.15420/ecr.2020.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2020.44</ArticleId><ArticleId IdType="pmc">PMC8145075</ArticleId><ArticleId IdType="pubmed">34040652</ArticleId></ArticleIdList></Reference><Reference><Citation>Semb A.G., Rollefstad S., Sexton J., Ikdahl E., Crowson C.S., van Riel P., Kitas G., Graham I., Kerola A.M., Surf-RA Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit. Int. J. Cardiol. Heart Vasc. 2022;42:101117. doi: 10.1016/j.ijcha.2022.101117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2022.101117</ArticleId><ArticleId IdType="pmc">PMC9479366</ArticleId><ArticleId IdType="pubmed">36118256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P., Haththotuwa R., Kwok C.S., Babu A., Kotronias R.A., Rushton C., Zaman A., Fryer A.A., Kadam U., Chew-Graham C.A., et al. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ. Cardiovasc. Qual. Outcomes. 2017;10:e003497. doi: 10.1161/CIRCOUTCOMES.116.003497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.116.003497</ArticleId><ArticleId IdType="pubmed">28228456</ArticleId></ArticleIdList></Reference><Reference><Citation>Thilaganathan B., Kalafat E. Cardiovascular System in Preeclampsia and Beyond. Hypertension. 2019;73:522&#x2013;531. doi: 10.1161/HYPERTENSIONAHA.118.11191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.118.11191</ArticleId><ArticleId IdType="pmc">PMC6380450</ArticleId><ArticleId IdType="pubmed">30712425</ArticleId></ArticleIdList></Reference><Reference><Citation>Corica B., Tartaglia F., Oliva A., Raparelli V., Cangemi R., Basili S., Lip G.Y.H., Proietti M., Romiti G.F. Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: A systematic review and meta-analysis. Intern. Emerg. Med. 2023;18:127&#x2013;135. doi: 10.1007/s11739-022-03135-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03135-1</ArticleId><ArticleId IdType="pmc">PMC9638315</ArticleId><ArticleId IdType="pubmed">36333574</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatla A., Mayer M.M., Adusumalli S., Hyman M.C., Oh E., Tierney A., Moss J., Chahal A.A., Anesi G., Denduluri S., et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17:1439&#x2013;1444. doi: 10.1016/j.hrthm.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7307518</ArticleId><ArticleId IdType="pubmed">32585191</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Granja P.E., Veras C., Aparisi &#xc1;., Amat-Santos I.J., Catal&#xe1; P., Marcos M., Cabez&#xf3;n G., Candela J., Gil J.F., Uribarri A., et al. Atrial fibrillation in patients with SARS-CoV-2 infection. Med. Clin. 2021;157:58&#x2013;63. doi: 10.1016/j.medcli.2021.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2021.01.003</ArticleId><ArticleId IdType="pmc">PMC7843022</ArticleId><ArticleId IdType="pubmed">33637334</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Abbas O., Alshaikhli A., Amran H.A. New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-19 Patient. Cureus. 2021;13:e12917. doi: 10.7759/cureus.12917.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12917</ArticleId><ArticleId IdType="pmc">PMC7906080</ArticleId><ArticleId IdType="pubmed">33654600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagnato G., Imbalzano E., Aragona C.O., Ioppolo C., Di Micco P., La Rosa D., Costa F., Micari A., Tomeo S., Zirilli N., et al. New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress. Medicina. 2022;58:530. doi: 10.3390/medicina58040530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58040530</ArticleId><ArticleId IdType="pmc">PMC9032834</ArticleId><ArticleId IdType="pubmed">35454369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanuri S.H., Jayesh Sirrkay P., Ulucay A.S. COVID-19 HEART unveiling as atrial fibrillation: Pathophysiology, management and future directions for research. Egypt. Heart J. 2023;75:36. doi: 10.1186/s43044-023-00359-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43044-023-00359-0</ArticleId><ArticleId IdType="pmc">PMC10149046</ArticleId><ArticleId IdType="pubmed">37120772</ArticleId></ArticleIdList></Reference><Reference><Citation>Duckheim M., Schreieck J. COVID-19 and Cardiac Arrhythmias. Hamostaseologie. 2021;41:372&#x2013;378. doi: 10.1055/a-1581-6881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1581-6881</ArticleId><ArticleId IdType="pubmed">34695853</ArticleId></ArticleIdList></Reference><Reference><Citation>Rav-Acha M., Orlev A., Itzhaki I., Zimmerman S.F., Fteiha B., Bohm D., Kurd R., Samuel T.Y., Asher E., Helviz Y., et al. Cardiac arrhythmias amongst hospitalised Coronavirus 2019 (COVID-19) patients: Prevalence, characterisation, and clinical algorithm to classify arrhythmic risk. Int. J. Clin. Pract. 2021;75:e13788. doi: 10.1111/ijcp.13788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13788</ArticleId><ArticleId IdType="pubmed">33128270</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouram S., Pannone L., Gauthey A., Sorgente A., Vergara P., Bisignani A., Monaco C., Mojica J., Al Housari M., Miraglia V., et al. Incidence and Predictors of Cardiac Arrhythmias in Patients with COVID-19. Front. Cardiovasc. Med. 2022;9:908177. doi: 10.3389/fcvm.2022.908177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.908177</ArticleId><ArticleId IdType="pmc">PMC9257009</ArticleId><ArticleId IdType="pubmed">35811696</ArticleId></ArticleIdList></Reference><Reference><Citation>Niehues P., Wegner F.K., Wolfes J., Willy K., Ellermann C., Vollenberg R., Reinecke H., Rosenow F., Lepper J., Sackarnd J., et al. Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS. J. Cardiol. 2022;80:298&#x2013;302. doi: 10.1016/j.jjcc.2022.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2022.04.010</ArticleId><ArticleId IdType="pmc">PMC9108971</ArticleId><ArticleId IdType="pubmed">35589465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Jiang Z., Meulendijks E.R., Baylan U., Waas I.S.E., Bugiani M., Tuinman P.R., Fronczek J., Heunks L.M.A., de Groot J.R., et al. Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patients. Cardiovasc. Pathol. 2023;64:107524. doi: 10.1016/j.carpath.2023.107524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2023.107524</ArticleId><ArticleId IdType="pmc">PMC9839463</ArticleId><ArticleId IdType="pubmed">36649811</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi J. The COVID Heart-One Year after SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks. JAMA. 2022;327:1113&#x2013;1114. doi: 10.1001/jama.2022.2411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.2411</ArticleId><ArticleId IdType="pubmed">35234824</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman A., Iglesias M., Khanna R., Beaulieu T. The association between COVID-19 infection and incident atrial fibrillation: Results from a retrospective cohort study using a large US commercial insurance database. Open Heart. 2023;10:e002399. doi: 10.1136/openhrt-2023-002399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2023-002399</ArticleId><ArticleId IdType="pmc">PMC10661058</ArticleId><ArticleId IdType="pubmed">37989491</ArticleId></ArticleIdList></Reference><Reference><Citation>Aza&#xf1;a G&#xf3;mez J., P&#xe9;rez-Belmonte L.M., Rubio-Rivas M., Bascu&#xf1;ana J., Quir&#xf3;s-L&#xf3;pez R., Mart&#xed;nez M.L.T., Hernandez E.M., Roque-Rojas F., M&#xe9;ndez-Bail&#xf3;n M., G&#xf3;mez-Huelgas R., et al. Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry. Med. Clin. 2022;159:457&#x2013;464. doi: 10.1016/j.medcli.2022.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2022.01.008</ArticleId><ArticleId IdType="pmc">PMC9579895</ArticleId><ArticleId IdType="pubmed">36275872</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubini-Costa R., Berm&#xfa;dez-Jim&#xe9;nez F., Rivera-L&#xf3;pez R., Sola-Garc&#xed;a E., Nagib-Raya H., Moreno-Escobar E., L&#xf3;pez-Z&#xfa;&#xf1;iga M.&#xc1;., Briones-Trav&#xe9;s A., Sanz-Herrera F., Sequ&#xed;-Sabater J.M., et al. Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection. Med. Clin. 2022;158:569&#x2013;575. doi: 10.1016/j.medcli.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8279935</ArticleId><ArticleId IdType="pubmed">34364707</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Rigatelli G., Bilato C., Zanon F., Zuliani G., Roncon L. Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients. J. Interv. Card. Electrophysiol. 2021;62:231&#x2013;238. doi: 10.1007/s10840-021-00992-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-021-00992-2</ArticleId><ArticleId IdType="pmc">PMC8046494</ArticleId><ArticleId IdType="pubmed">33855639</ArticleId></ArticleIdList></Reference><Reference><Citation>Musikantow D.R., Turagam M.K., Sartori S., Chu E., Kawamura I., Shivamurthy P., Bokhari M., Oates C., Zhang C., Pumill C., et al. Atrial Fibrillation in Patients Hospitalized with COVID-19: Incidence, Predictors, Outcomes, and Comparison to Influenza. JACC Clin. Electrophysiol. 2021;7:1120&#x2013;1130. doi: 10.1016/j.jacep.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC7904279</ArticleId><ArticleId IdType="pubmed">33895107</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo Sanz A., Salido Tahoces L., Ortega P&#xe9;rez R., Gonz&#xe1;lez Ferrer E., S&#xe1;nchez Recalde &#xc1;., Zamorano G&#xf3;mez J.L. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. Cardiol. J. 2021;28:34&#x2013;40. doi: 10.5603/CJ.a2020.0145.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2020.0145</ArticleId><ArticleId IdType="pmc">PMC8105065</ArticleId><ArticleId IdType="pubmed">33140386</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo B., Zhao C., He M.Z., Senter C., Zhou Z., Peng J., Li S., Fitzpatrick A.L., Lindstrom S., Stebbins R.C., et al. Identifying patterns of reported findings on long-term cardiac complications of COVID-19: A systematic review and meta-analysis. BMC Med. 2023;21:468. doi: 10.1186/s12916-023-03162-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03162-5</ArticleId><ArticleId IdType="pmc">PMC10685580</ArticleId><ArticleId IdType="pubmed">38017426</ArticleId></ArticleIdList></Reference><Reference><Citation>Huseynov A., Akin I., Duerschmied D., Scharf R.E. Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment. Viruses. 2023;15:389. doi: 10.3390/v15020389.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020389</ArticleId><ArticleId IdType="pmc">PMC9959721</ArticleId><ArticleId IdType="pubmed">36851603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pari B., Babbili A., Kattubadi A., Thakre A., Thotamgari S., Gopinathannair R., Olshansky B., Dominic P. COVID-19 Vaccination and Cardiac Arrhythmias: A Review. Curr. Cardiol. Rep. 2023;25:925&#x2013;940. doi: 10.1007/s11886-023-01921-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-023-01921-7</ArticleId><ArticleId IdType="pubmed">37530946</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey A.J., Greiner M.A., Heckbert S.R., Jensen P.N., Piccini J.P., Sinner M.F., Curtis L.H., Benjamin E.J. Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: Incidence and risk factors. Am. Heart J. 2013;165:949&#x2013;955.e943. doi: 10.1016/j.ahj.2013.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2013.03.020</ArticleId><ArticleId IdType="pmc">PMC3695631</ArticleId><ArticleId IdType="pubmed">23708166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuipers S., Klein Klouwenberg P.M.C., Cremer O.L. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review. Crit. Care. 2014;18:688. doi: 10.1186/s13054-014-0688-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0688-5</ArticleId><ArticleId IdType="pmc">PMC4296551</ArticleId><ArticleId IdType="pubmed">25498795</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein Klouwenberg P.M.C., Frencken J.F., Kuipers S., Ong D.S.Y., Peelen L.M., van Vught L.A., Schultz M.J., van der Poll T., Bonten M.J., Cremer O.L., et al. Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with Sepsis. A Cohort Study. Am. J. Respir. Crit. Care Med. 2017;195:205&#x2013;211. doi: 10.1164/rccm.201603-0618OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201603-0618OC</ArticleId><ArticleId IdType="pubmed">27467907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch N.A., Cohen D.M., Walkey A.J. Risk Factors for New-Onset Atrial Fibrillation in Patients with Sepsis: A Systematic Review and Meta-Analysis. Crit. Care Med. 2019;47:280&#x2013;287. doi: 10.1097/CCM.0000000000003560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003560</ArticleId><ArticleId IdType="pmc">PMC9872909</ArticleId><ArticleId IdType="pubmed">30653473</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashar S.K., Hossain M.B., Ding E., Walkey A.J., McManus D.D., Chon K.H. Atrial Fibrillation Detection During Sepsis: Study on MIMIC III ICU Data. IEEE J. Biomed. Health Inform. 2020;24:3124&#x2013;3135. doi: 10.1109/JBHI.2020.2995139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2020.2995139</ArticleId><ArticleId IdType="pmc">PMC7670858</ArticleId><ArticleId IdType="pubmed">32750900</ArticleId></ArticleIdList></Reference><Reference><Citation>Aibar J., Schulman S. New-Onset Atrial Fibrillation in Sepsis: A Narrative Review. Semin. Thromb. Hemost. 2021;47:18&#x2013;25. doi: 10.1055/s-0040-1714400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1714400</ArticleId><ArticleId IdType="pubmed">32968991</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietti M., Romiti G.F. Management of Ventricular Heart Rate in Atrial Fibrillation Patients with Sepsis. Chest. 2021;159:1315&#x2013;1316. doi: 10.1016/j.chest.2020.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.12.034</ArticleId><ArticleId IdType="pubmed">34021986</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F.P., Chen M.Y., Wang L., He H., Jia Z.Q., Kuai L., Zhou H.B., Liu M., Hong M. Outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis of 225,841 patients. Am. J. Emerg. Med. 2021;42:23&#x2013;30. doi: 10.1016/j.ajem.2020.12.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.12.062</ArticleId><ArticleId IdType="pubmed">33429188</ArticleId></ArticleIdList></Reference><Reference><Citation>Induruwa I., Hennebry E., Hennebry J., Thakur M., Warburton E.A., Khadjooi K. Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation? Eur. J. Intern. Med. 2022;98:32&#x2013;36. doi: 10.1016/j.ejim.2021.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.10.022</ArticleId><ArticleId IdType="pmc">PMC8948090</ArticleId><ArticleId IdType="pubmed">34763982</ArticleId></ArticleIdList></Reference><Reference><Citation>Corica B., Romiti G.F., Basili S., Proietti M. Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis. J. Pers. Med. 2022;12:547. doi: 10.3390/jpm12040547.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12040547</ArticleId><ArticleId IdType="pmc">PMC9026551</ArticleId><ArticleId IdType="pubmed">35455662</ArticleId></ArticleIdList></Reference><Reference><Citation>Honorato M.O., Sousa Filho J.T., Honorato Junior L.F.B., Watanabe N., Goulart G.M., Prado R.R.D. Atrial Fibrillation and Sepsis in Elderly Patients and Their Associaton with In-Hospital Mortality. Arq. Bras. Cardiol. 2023;120:e20220295. doi: 10.36660/abc.20220295.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/abc.20220295</ArticleId><ArticleId IdType="pmc">PMC9972940</ArticleId><ArticleId IdType="pubmed">36921155</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes M., Welters I.D., Johnston B.W. Study protocol: A systematic review and meta-analysis regarding the influence of coagulopathy and immune activation on new onset atrial fibrillation in patients with sepsis. PLoS ONE. 2023;18:e0290963. doi: 10.1371/journal.pone.0290963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0290963</ArticleId><ArticleId IdType="pmc">PMC10490925</ArticleId><ArticleId IdType="pubmed">37683020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Gamez E., Burnham K.L., Goh C., Allcock A., Malick Z.H., Overend L., Kwok A., Smith D.A., Peters-Sengers H., Antcliffe D., et al. An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression. Sci. Transl. Med. 2022;14:eabq4433. doi: 10.1126/scitranslmed.abq4433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq4433</ArticleId><ArticleId IdType="pmc">PMC7613832</ArticleId><ArticleId IdType="pubmed">36322631</ArticleId></ArticleIdList></Reference><Reference><Citation>van Amstel R.B.E., Kennedy J.N., Scicluna B.P., Bos L.D.J., Peters-Sengers H., Butler J.M., Cano-Gamez E., Knight J.C., Vlaar A.P.J., Cremer O.L., et al. Uncovering heterogeneity in sepsis: A comparative analysis of subphenotypes. Intensive Care Med. 2023;49:1360&#x2013;1369. doi: 10.1007/s00134-023-07239-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07239-w</ArticleId><ArticleId IdType="pmc">PMC10622359</ArticleId><ArticleId IdType="pubmed">37851064</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. To what extent are the terminal stages of sepsis, septic shock, SIRS, and multiple organ dysfunction syndrome actually driven by a toxic prion/amyloid form of fibrin? Semin. Thromb. Hemost. 2018;44:224&#x2013;238. doi: 10.1055/s-0037-1604108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1604108</ArticleId><ArticleId IdType="pmc">PMC6193370</ArticleId><ArticleId IdType="pubmed">28778104</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Mbotwe S., Bester J., Robinson C., Kell D.B. Acute induction of anomalous blood clotting by highly substoichiometric levels of bacterial lipopolysaccharide (LPS). bioRxiv version. bioRxiv. 2016:2016-053538v053531. doi: 10.1101/053538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/053538</ArticleId><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Kell D.B. A perspective on how microscopy imaging of fibrinaloid microclots and platelet pathology may be applied in clinical investigations. Semin. Thromb. Haemost. 2023 doi: 10.1055/s-0043-1774796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1774796</ArticleId><ArticleId IdType="pmc">PMC11105946</ArticleId><ArticleId IdType="pubmed">37748515</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., van der Poll T., ten Cate H., van Deventer S.J. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur. J. Clin. Investig. 1997;27:3&#x2013;9. doi: 10.1046/j.1365-2362.1997.570614.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2362.1997.570614.x</ArticleId><ArticleId IdType="pubmed">9041370</ArticleId></ArticleIdList></Reference><Reference><Citation>Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit. Care Med. 2010;38:S35&#x2013;S42. doi: 10.1097/CCM.0b013e3181c9e31d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181c9e31d</ArticleId><ArticleId IdType="pubmed">20083912</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M. The coagulant response in sepsis and inflammation. Hamostaseologie. 2010;30:10&#x2013;16. doi: 10.1055/s-0037-1617143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617143</ArticleId><ArticleId IdType="pubmed">20162247</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Nagaoka I., Boulat M. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation. Thromb. Res. 2013;131:383&#x2013;389. doi: 10.1016/j.thromres.2013.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2013.03.012</ArticleId><ArticleId IdType="pubmed">23566533</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen K.S., Sawheny E., Kinasewitz G.T. Anticoagulant modulation of inflammation in severe sepsis. World J. Crit. Care Med. 2015;4:105&#x2013;115. doi: 10.5492/wjccm.v4.i2.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.5492/wjccm.v4.i2.105</ArticleId><ArticleId IdType="pmc">PMC4411562</ArticleId><ArticleId IdType="pubmed">25938026</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Ma X. The role of heparin in sepsis: Much more than just an anticoagulant. Br. J. Haematol. 2017;179:389&#x2013;398. doi: 10.1111/bjh.14885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.14885</ArticleId><ArticleId IdType="pubmed">28832958</ArticleId></ArticleIdList></Reference><Reference><Citation>Murao S., Yamakawa K. A Systematic Summary of Systematic Reviews on Anticoagulant Therapy in Sepsis. J. Clin. Med. 2019;8:1869. doi: 10.3390/jcm8111869.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8111869</ArticleId><ArticleId IdType="pmc">PMC6912821</ArticleId><ArticleId IdType="pubmed">31689983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S., Ma X., Li X. Phenotype-oriented anticoagulant therapy for sepsis: Still a work in progress. Int. J. Hematol. 2022;116:48&#x2013;54. doi: 10.1007/s12185-022-03337-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-022-03337-5</ArticleId><ArticleId IdType="pubmed">35380387</ArticleId></ArticleIdList></Reference><Reference><Citation>Meziani F., Gando S., Vincent J.L. Should all patients with sepsis receive anticoagulation? Yes. Intensive Care Med. 2017;43:452&#x2013;454. doi: 10.1007/s00134-016-4621-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4621-z</ArticleId><ArticleId IdType="pubmed">28194512</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarlatescu E., Tomescu D., Arama S.S. Anticoagulant Therapy in Sepsis. The Importance of Timing. J. Crit. Care Med. 2017;3:63&#x2013;69. doi: 10.1515/jccm-2017-0011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jccm-2017-0011</ArticleId><ArticleId IdType="pmc">PMC5769917</ArticleId><ArticleId IdType="pubmed">29967873</ArticleId></ArticleIdList></Reference><Reference><Citation>Umemura Y., Yamakawa K. Optimal patient selection for anticoagulant therapy in sepsis: An evidence-based proposal from Japan. J. Thromb. Haemost. 2018;16:462&#x2013;464. doi: 10.1111/jth.13946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13946</ArticleId><ArticleId IdType="pubmed">29316171</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi W., Liu J., Li A. Effect of Anticoagulant versus Non-Anticoagulant Therapy on Mortality of Sepsis-Induced Disseminated Intravascular Coagulation: A Systematic Review and Meta-Analysis. Clin. Appl. Thromb. Hemost. 2023;29:10760296231157766. doi: 10.1177/10760296231157766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296231157766</ArticleId><ArticleId IdType="pmc">PMC9941593</ArticleId><ArticleId IdType="pubmed">36802946</ArticleId></ArticleIdList></Reference><Reference><Citation>Umemura Y., Nishida T., Yamakawa K., Ogura H., Oda J., Fujimi S. Anticoagulant therapies against sepsis-induced disseminated intravascular coagulation. Acute Med. Surg. 2023;10:e884. doi: 10.1002/ams2.884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ams2.884</ArticleId><ArticleId IdType="pmc">PMC10475981</ArticleId><ArticleId IdType="pubmed">37670904</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustamante A., Garcia-Berrocoso T., Penalba A., Giralt D., Simats A., Muchada M., Zapata E., Rubiera M., Montaner J. Sepsis biomarkers reprofiling to predict stroke-associated infections. J. Neuroimmunol. 2017;312:19&#x2013;23. doi: 10.1016/j.jneuroim.2017.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2017.08.012</ArticleId><ArticleId IdType="pubmed">28886956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishore A.K., Vail A., Jeans A.R., Chamorro A., Di Napoli M., Kalra L., Langhorne P., Roffe C., Westendorp W., Nederkoorn P.J., et al. Microbiological Etiologies of Pneumonia Complicating Stroke: A Systematic Review. Stroke. 2018;49:1602&#x2013;1609. doi: 10.1161/STROKEAHA.117.020250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.020250</ArticleId><ArticleId IdType="pubmed">29915122</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim R., Wong C.H.Y. Ischemia, Immunosuppression and Infection--Tackling the Predicaments of Post-Stroke Complications. Int. J. Mol. Sci. 2016;17:64. doi: 10.3390/ijms17010064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17010064</ArticleId><ArticleId IdType="pmc">PMC4730309</ArticleId><ArticleId IdType="pubmed">26742037</ArticleId></ArticleIdList></Reference><Reference><Citation>Westendorp W.F., Vermeij J.D., Hilkens N.A., Brouwer M.C., Algra A., van der Worp H.B., Dippel D.W.J., van de Beek D., Nederkoorn P.J., PASS-Investigators Development and internal validation of a prediction rule for post-stroke infection and post-stroke pneumonia in acute stroke patients. Eur. Stroke J. 2018;3:136&#x2013;144. doi: 10.1177/2396987318764519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2396987318764519</ArticleId><ArticleId IdType="pmc">PMC5992742</ArticleId><ArticleId IdType="pubmed">29900413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemi S., Pourgholaminejad A., Saberi A. Stroke Associated with SARS-CoV-2 Infection and its Pathogenesis: A Systematic Review. Basic. Clin. Neurosci. 2021;12:569&#x2013;586. doi: 10.32598/bcn.2021.3277.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.32598/bcn.2021.3277.1</ArticleId><ArticleId IdType="pmc">PMC8818122</ArticleId><ArticleId IdType="pubmed">35173912</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeij F.H., Scholte op Reimer W.J., de Man P., van Oostenbrugge R.J., Franke C.L., de Jong G., de Kort P.L., Dippel D.W., Netherlands Stroke Survey I. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: Data from the Netherlands Stroke Survey. Cerebrovasc. Dis. 2009;27:465&#x2013;471. doi: 10.1159/000210093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000210093</ArticleId><ArticleId IdType="pubmed">19329851</ArticleId></ArticleIdList></Reference><Reference><Citation>Westendorp W.F., Nederkoorn P.J., Vermeij J.D., Dijkgraaf M.G., van de Beek D. Post-stroke infection: A systematic review and meta-analysis. BMC Neurol. 2011;11:110. doi: 10.1186/1471-2377-11-110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-110</ArticleId><ArticleId IdType="pmc">PMC3185266</ArticleId><ArticleId IdType="pubmed">21933425</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;l&#xe9; N., Turc G. Stroke Associated With Recent Mycoplasma pneumoniae Infection: A Systematic Review of Clinical Features and Presumed Pathophysiological Mechanisms. Front. Neurol. 2018;9:1109. doi: 10.3389/fneur.2018.01109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01109</ArticleId><ArticleId IdType="pmc">PMC6308181</ArticleId><ArticleId IdType="pubmed">30622505</ArticleId></ArticleIdList></Reference><Reference><Citation>Haak B.W., Westendorp W.F., van Engelen T.S.R., Brands X., Brouwer M.C., Vermeij J.D., Hugenholtz F., Verhoeven A., Derks R.J., Giera M., et al. Disruptions of Anaerobic Gut Bacteria Are Associated with Stroke and Post-stroke Infection: A Prospective Case-Control Study. Transl. Stroke Res. 2021;12:581&#x2013;592. doi: 10.1007/s12975-020-00863-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-020-00863-4</ArticleId><ArticleId IdType="pmc">PMC8213601</ArticleId><ArticleId IdType="pubmed">33052545</ArticleId></ArticleIdList></Reference><Reference><Citation>Westendorp W.F., Vermeij J.D., Zock E., Hooijenga I.J., Kruyt N.D., Bosboom H.J.L.W., Kwa V.I., Weisfelt M., Remmers M.J.M., ten Houten R., et al. The Preventive Antibiotics in Stroke Study (PASS): A pragmatic randomised open-label masked endpoint clinical trial. Lancet. 2015;385:1519&#x2013;1526. doi: 10.1016/S0140-6736(14)62456-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)62456-9</ArticleId><ArticleId IdType="pubmed">25612858</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra L., Irshad S., Hodsoll J., Simpson M., Gulliford M., Smithard D., Patel A., Rebollo-Mesa I., Investigators S.-I. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): A prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet. 2015;386:1835&#x2013;1844. doi: 10.1016/S0140-6736(15)00126-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00126-9</ArticleId><ArticleId IdType="pubmed">26343840</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeij J.D., Westendorp W.F., Dippel D.W.J., van de Beek D., Nederkoorn P.J. Antibiotic therapy for preventing infections in people with acute stroke. Cochrane Database Syst. Rev. 2018;1:CD008530. doi: 10.1002/14651858.CD008530.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008530.pub3</ArticleId><ArticleId IdType="pmc">PMC6491314</ArticleId><ArticleId IdType="pubmed">29355906</ArticleId></ArticleIdList></Reference><Reference><Citation>Westendorp W.F., Vermeij J.D., Smith C.J., Kishore A.K., Hodsoll J., Kalra L., Meisel A., Chamorro A., Chang J.J., Rezaei Y., et al. Preventive antibiotic therapy in acute stroke patients: A systematic review and meta-analysis of individual patient data of randomized controlled trials. Eur. Stroke J. 2021;6:385&#x2013;394. doi: 10.1177/23969873211056445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23969873211056445</ArticleId><ArticleId IdType="pmc">PMC8948510</ArticleId><ArticleId IdType="pubmed">35342808</ArticleId></ArticleIdList></Reference><Reference><Citation>Badve M.S., Zhou Z., Anderson C.S., Hackett M.L. Effectiveness and Safety of Antibiotics for Preventing Pneumonia and Improving Outcome after Acute Stroke: Systematic Review and Meta-analysis. J. Stroke Cerebrovasc. Dis. 2018;27:3137&#x2013;3147. doi: 10.1016/j.jstrokecerebrovasdis.2018.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2018.07.001</ArticleId><ArticleId IdType="pubmed">30093207</ArticleId></ArticleIdList></Reference><Reference><Citation>Badve M.S., Zhou Z., van de Beek D., Anderson C.S., Hackett M.L. Frequency of post-stroke pneumonia: Systematic review and meta-analysis of observational studies. Int. J. Stroke. 2019;14:125&#x2013;136. doi: 10.1177/1747493018806196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493018806196</ArticleId><ArticleId IdType="pubmed">30346258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluis W.M., Westendorp W.F., van de Beek D., Nederkoorn P.J., van der Worp H.B. Preventive ceftriaxone in patients at high risk of stroke-associated pneumonia. A post-hoc analysis of the PASS trial. PLoS ONE. 2022;17:e0279700. doi: 10.1371/journal.pone.0279700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0279700</ArticleId><ArticleId IdType="pmc">PMC9803205</ArticleId><ArticleId IdType="pubmed">36584124</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson J.J., Kropp H. beta-Lactam antibiotic-induced release of free endotoxin: In vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J. Infect. Dis. 1992;165:1033&#x2013;1041. doi: 10.1093/infdis/165.6.1033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/165.6.1033</ArticleId><ArticleId IdType="pubmed">1583320</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal S.M., Horn D.L., Palardy J.E., Parejo N., Jhung J., Bhattacharjee A., Young L.D. The in vivo significance of antibiotic-induced endotoxin release in experimental Gram-negative sepsis. J. Endotox Res. 1996;3:245&#x2013;252. doi: 10.1177/096805199600300310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096805199600300310</ArticleId></ArticleIdList></Reference><Reference><Citation>van Langevelde P., Kwappenberg K.M., Groeneveld P.H., Mattie H., van Dissel J.T. Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: Delay between killing by ceftazidime and imipenem and release of LPS. Antimicrob. Agents Chemother. 1998;42:739&#x2013;743. doi: 10.1128/AAC.42.4.739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.42.4.739</ArticleId><ArticleId IdType="pmc">PMC105534</ArticleId><ArticleId IdType="pubmed">9559775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mickiewicz K.M., Kawai Y., Drage L., Gomes M.C., Davison F., Pickard R., Hall J., Mostowy S., Aldridge P.D., Errington J. Possible role of L-form switching in recurrent urinary tract infection. Nat. Commun. 2019;10:4379. doi: 10.1038/s41467-019-12359-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12359-3</ArticleId><ArticleId IdType="pmc">PMC6763468</ArticleId><ArticleId IdType="pubmed">31558767</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.K., Wang J.H., Lei W.Y., Chen C.L., Chang C.Y., Liou L.S. Helicobacter pylori infection is associated with an increased risk of Parkinson&#x2019;s disease: A population-based retrospective cohort study. Park. Relat. Disord. 2018;47:26&#x2013;31. doi: 10.1016/j.parkreldis.2017.11.331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2017.11.331</ArticleId><ArticleId IdType="pubmed">29174171</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E., Tsouris Z., Mentis A.A., Siokas V., Michalopoulou A., Sokratous M., Dastamani M., Bogdanos D.P., Deretzi G., Kountouras J. H. pylori and Parkinson&#x2019;s disease: Meta-analyses including clinical severity. Clin. Neurol. Neurosurg. 2018;175:16&#x2013;24. doi: 10.1016/j.clineuro.2018.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2018.09.039</ArticleId><ArticleId IdType="pubmed">30308319</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L., Shen L., Ji H.F. Impact of infection on risk of Parkinson&#x2019;s disease: A quantitative assessment of case-control and cohort studies. J. Neurovirol. 2019;25:221&#x2013;228. doi: 10.1007/s13365-018-0707-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-018-0707-4</ArticleId><ArticleId IdType="pubmed">30632012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Liu X., Tan C., Zhou W., Jiang J., Peng W., Zhou X., Mo L., Chen L. Bacterial, viral, and fungal infection-related risk of Parkinson&#x2019;s disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10:e01549. doi: 10.1002/brb3.1549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1549</ArticleId><ArticleId IdType="pmc">PMC7066372</ArticleId><ArticleId IdType="pubmed">32017453</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeyne R.J., Noyce A.J., Byrne M., Savica R., Marras C. Infection and Risk of Parkinson&#x2019;s Disease. J. Park. Dis. 2021;11:31&#x2013;43. doi: 10.3233/JPD-202279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202279</ArticleId><ArticleId IdType="pmc">PMC7990414</ArticleId><ArticleId IdType="pubmed">33361610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen L.F., Nordestgaard B.G., Schnohr P., Ellervik C. Increased Ferritin Concentration and Risk of Atrial Fibrillation and Heart Failure in Men and Women: Three Studies of the Danish General Population Including 35,799 Individuals. Clin. Chem. 2019;65:180&#x2013;188. doi: 10.1373/clinchem.2018.292763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2018.292763</ArticleId><ArticleId IdType="pubmed">30459161</ArticleId></ArticleIdList></Reference><Reference><Citation>Altieri C., Pisano C., Vincenzo L., Ferrante M.S., Pellerito V., Nardi P., Bassano C., Buioni D., Greco E., Ruvolo G., et al. Circulating Levels of Ferritin, RDW, PTLs as Predictive Biomarkers of Postoperative Atrial Fibrillation Risk after Cardiac Surgery in Extracorporeal Circulation. Int. J. Mol. Sci. 2022;23:14800. doi: 10.3390/ijms232314800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314800</ArticleId><ArticleId IdType="pmc">PMC9741292</ArticleId><ArticleId IdType="pubmed">36499124</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell D.H. gamma&#x2019; Fibrinogen as a novel marker of thrombotic disease. Clin. Chem. Lab. Med. 2012;50:1903&#x2013;1909. doi: 10.1515/cclm-2012-0005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2012-0005</ArticleId><ArticleId IdType="pubmed">23091268</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyendyk J.P., Schoenecker J.G., Flick M.J. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood. 2019;133:511&#x2013;520. doi: 10.1182/blood-2018-07-818211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-07-818211</ArticleId><ArticleId IdType="pmc">PMC6367649</ArticleId><ArticleId IdType="pubmed">30523120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Lowe G.D., Rumley A., Dunn F.G. Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of warfarin treatment. Br. Heart J. 1995;73:527&#x2013;533. doi: 10.1136/hrt.73.6.527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.73.6.527</ArticleId><ArticleId IdType="pmc">PMC483914</ArticleId><ArticleId IdType="pubmed">7626351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Lowe G.D., Rumley A., Dunn F.G. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence for intermediate elevated levels of intravascular thrombogenesis. Am. Heart J. 1996;131:724&#x2013;730. doi: 10.1016/S0002-8703(96)90278-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8703(96)90278-1</ArticleId><ArticleId IdType="pubmed">8721646</ArticleId></ArticleIdList></Reference><Reference><Citation>Li-Saw-Hee F.L., Blann A.D., Gurney D., Lip G.Y. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur. Heart J. 2001;22:1741&#x2013;1747. doi: 10.1053/euhj.2000.2531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/euhj.2000.2531</ArticleId><ArticleId IdType="pubmed">11511124</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lecce V.N., Loffredo L., Fimognari F.L., Cangemi R., Violi F. Fibrinogen as predictor of ischemic stroke in patients with non-valvular atrial fibrillation. J. Thromb. Haemost. 2003;1:2453&#x2013;2455. doi: 10.1046/j.1538-7836.2003.0468d.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1538-7836.2003.0468d.x</ArticleId><ArticleId IdType="pubmed">14629486</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal K.J., Tolstrup J.S., Friberg J., Gronbaek M., Jensen G. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study) Am. J. Cardiol. 2006;98:75&#x2013;81. doi: 10.1016/j.amjcard.2006.01.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2006.01.067</ArticleId><ArticleId IdType="pubmed">16784925</ArticleId></ArticleIdList></Reference><Reference><Citation>Weymann A., Sabashnikov A., Ali-Hasan-Al-Saegh S., Popov A.F., Jalil Mirhosseini S., Baker W.L., Lotfaliani M., Liu T., Dehghan H., Yavuz S., et al. Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review. Med. Sci. Monit. Basic. Res. 2017;23:97&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5452871</ArticleId><ArticleId IdType="pubmed">28360407</ArticleId></ArticleIdList></Reference><Reference><Citation>Semczuk-Kaczmarek K., Platek A.E., Rys A., Adamowicz J., Legosz P., Kotkowski M., Dudzik-Plocica A., Gorko D., Szymanski F.M., Filipiak K.J. CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation. Adv. Clin. Exp. Med. 2019;28:1451&#x2013;1457. doi: 10.17219/acem/104557.</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/104557</ArticleId><ArticleId IdType="pubmed">31596555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafaqat S., Afzal S., Khurshid H., Safdar S., Rafaqat S., Rafaqat S. The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation. J. Innov. Card. Rhythm. Manag. 2022;13:5265&#x2013;5277. doi: 10.19102/icrm.2022.13125.</Citation><ArticleIdList><ArticleId IdType="doi">10.19102/icrm.2022.13125</ArticleId><ArticleId IdType="pmc">PMC10246921</ArticleId><ArticleId IdType="pubmed">37293559</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao J., Gao Z., Hu Y., Liu W., Ye L., Wang L. Serum fibrinogen-to-albumin ratio predicts new-onset atrial fibrillation risk during hospitalization in patients with acute myocardial infarction after percutaneous coronary intervention: A retrospective study. BMC Cardiovasc. Disord. 2023;23:432. doi: 10.1186/s12872-023-03480-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-023-03480-9</ArticleId><ArticleId IdType="pmc">PMC10474692</ArticleId><ArticleId IdType="pubmed">37658287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilly M.J., Geurts S., Pezzullo A.M., Bramer W.M., de Groot N.M.S., Kavousi M., de Maat M.P.M. The association of coagulation and atrial fibrillation: A systematic review and meta-analysis. Europace. 2023;25:28&#x2013;39. doi: 10.1093/europace/euac130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euac130</ArticleId><ArticleId IdType="pmc">PMC9907526</ArticleId><ArticleId IdType="pubmed">35942591</ArticleId></ArticleIdList></Reference><Reference><Citation>Drabik L., Wolkow P., Undas A. Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients with Atrial Fibrillation. Stroke. 2017;48:2716&#x2013;2722. doi: 10.1161/STROKEAHA.117.018143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.018143</ArticleId><ArticleId IdType="pubmed">28904234</ArticleId></ArticleIdList></Reference><Reference><Citation>Drabik L., Konieczynska M., Undas A. Clot Lysis Time Predicts Stroke during Anticoagulant Therapy in Patients with Atrial Fibrillation. Can. J. Cardiol. 2020;36:119&#x2013;126. doi: 10.1016/j.cjca.2019.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2019.08.001</ArticleId><ArticleId IdType="pubmed">31740169</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquissi F.C. The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio Mirror. J. Biomark. 2016;2016:8160393. doi: 10.1155/2016/8160393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8160393</ArticleId><ArticleId IdType="pmc">PMC4947500</ArticleId><ArticleId IdType="pubmed">27446629</ArticleId></ArticleIdList></Reference><Reference><Citation>Korantzopoulos P., Letsas K.P., Tse G., Fragakis N., Goudis C.A., Liu T. Inflammation and atrial fibrillation: A comprehensive review. J. Arrhythm. 2018;34:394&#x2013;401. doi: 10.1002/joa3.12077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/joa3.12077</ArticleId><ArticleId IdType="pmc">PMC6111477</ArticleId><ArticleId IdType="pubmed">30167010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n F., Roldan V., Monmeneu J.V., Bod&#xed; V., Fern&#xe1;ndez C., Gar&#xed;a de Burgos F., Marco P., Sogorb F. Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation. Am. J. Cardiol. 1999;84:862&#x2013;864. doi: 10.1016/S0002-9149(99)00453-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(99)00453-1</ArticleId><ArticleId IdType="pubmed">10513790</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius M., Donahue B.S., Yu C., Greelish J.P., Roden D.M., Brown N.J. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Circulation. 2007;116:I1&#x2013;I7. doi: 10.1161/CIRCULATIONAHA.106.677906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.677906</ArticleId><ArticleId IdType="pubmed">17846288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Lai Y., Gao X., Li X., Deng C.Y., Guo H., Zhao J., Yang H., Xu Y., Wu S., et al. Involvement of plasminogen activator inhibitor-1 and its related molecules in atrial fibrosis in patients with atrial fibrillation. PeerJ. 2021;9:e11488. doi: 10.7717/peerj.11488.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.11488</ArticleId><ArticleId IdType="pmc">PMC8179226</ArticleId><ArticleId IdType="pubmed">34141473</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi K., Furui H., Taniguchi N., Sotobata I. Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation. Jpn. Heart J. 1986;27:481&#x2013;487. doi: 10.1536/ihj.27.481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.27.481</ArticleId><ArticleId IdType="pubmed">2946878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohara H., Amitani S., Kurose M., Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation. J. Am. Coll. Cardiol. 1997;29:106&#x2013;112. doi: 10.1016/S0735-1097(96)00427-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(96)00427-5</ArticleId><ArticleId IdType="pubmed">8996302</ArticleId></ArticleIdList></Reference><Reference><Citation>Drabik L., Wolkow P., Undas A. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: Association with thrombin generation, endothelial injury and platelet activation. Thromb. Res. 2015;136:408&#x2013;414. doi: 10.1016/j.thromres.2015.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2015.05.028</ArticleId><ArticleId IdType="pubmed">26048399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Lip P.L., Zarifis J., Watson R.D.S., Bareford D., Lowe G.D.O., Beevers D.G. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation. 1996;94:425&#x2013;431. doi: 10.1161/01.CIR.94.3.425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.94.3.425</ArticleId><ArticleId IdType="pubmed">8759084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamath S., Blann A.D., Chin B.S., Lanza F., Aleil B., Cazenave J.P., Lip G.Y.H. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur. Heart J. 2002;23:1788&#x2013;1795. doi: 10.1053/euhj.2002.3259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/euhj.2002.3259</ArticleId><ArticleId IdType="pubmed">12419299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaura A., Arnold A.D., Panoulas V., Glampson B., Davies J., Mulla A., Woods K., Omigie J., Shah A.D., Channon K.M., et al. Prognostic significance of troponin level in 3121 patients presenting with atrial fibrillation (The NIHR Health Informatics Collaborative TROP-AF study) J. Am. Heart Assoc. 2020;9:e013684. doi: 10.1161/JAHA.119.013684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.013684</ArticleId><ArticleId IdType="pmc">PMC7428631</ArticleId><ArticleId IdType="pubmed">32212911</ArticleId></ArticleIdList></Reference><Reference><Citation>Costabel J.P., Burgos L.M., Trivi M. The Significance of Troponin Elevation in Atrial Fibrillation. J. Atr. Fibrillation. 2017;9:1530. doi: 10.4022/jafib.1530.</Citation><ArticleIdList><ArticleId IdType="doi">10.4022/jafib.1530</ArticleId><ArticleId IdType="pmc">PMC5673337</ArticleId><ArticleId IdType="pubmed">29250287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Guo S.D., Liu Y., Ma C.S., Lip G.Y.H. Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: A systematic review, meta-analysis and meta-regression. Biomarkers. 2018;23:512&#x2013;517. doi: 10.1080/1354750X.2018.1463562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1354750X.2018.1463562</ArticleId><ArticleId IdType="pubmed">29631448</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepehri Shamloo A., Arya A., Darma A., Nedios S., Doring M., Bollmann A., Dagres N., Hindricks G. Atrial fibrillation: Is there a role for cardiac troponin? Diagnosis. 2021;8:295&#x2013;303. doi: 10.1515/dx-2019-0072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2019-0072</ArticleId><ArticleId IdType="pubmed">31913848</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucrecia Maria B., Marcelo T., Andreina G.R., Juan Pablo C. Prognostic Value of Troponin in Patients with Atrial Fibrillation Admitted to an Emergency Department: Review and Meta-Analysis. J. Atr. Fibrillation. 2020;13:2346. doi: 10.4022/jafib.2346.</Citation><ArticleIdList><ArticleId IdType="doi">10.4022/jafib.2346</ArticleId><ArticleId IdType="pmc">PMC8691335</ArticleId><ArticleId IdType="pubmed">34950306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s M., Arbucci R., Lambardi F., Furmento J., Mu&#xf1;oz F., Viruel M., Alexander B., Baranchuk A., Costabel J.P. High-Sensitivity Troponin T for The Risk Assessment of Patients with Acute Atrial Fibrillation. Curr. Probl. Cardiol. 2022;47:101079. doi: 10.1016/j.cpcardiol.2021.101079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2021.101079</ArticleId><ArticleId IdType="pubmed">34923030</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C., Maphumulo S.C., Grobbelaar L.M., Bredenkamp J., Laubscher J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. COVID-19: The Rollercoaster of Fibrin(ogen), D-dimer, von Willebrand Factor, P-selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Int. J. Mol. Sci. 2020;21:5168. doi: 10.3390/ijms21145168.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145168</ArticleId><ArticleId IdType="pmc">PMC7403995</ArticleId><ArticleId IdType="pubmed">32708334</ArticleId></ArticleIdList></Reference><Reference><Citation>Freestone B., Gustafsson F., Chong A.Y., Corell P., Kistorp C., Hildebrandt P., Lip G.Y.H. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. Chest. 2008;133:1203&#x2013;1208. doi: 10.1378/chest.07-2557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.07-2557</ArticleId><ArticleId IdType="pubmed">18339785</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong C., Xin M., He L., Sun G., Shen F. Prognostic value of von Willebrand factor in patients with atrial fibrillation: A meta-analysis. Medicine. 2018;97:e11269. doi: 10.1097/MD.0000000000011269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011269</ArticleId><ArticleId IdType="pmc">PMC6076195</ArticleId><ArticleId IdType="pubmed">29979393</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n F., Roldan V., Lip G.Y.H. Fibrinolytic function and atrial fibrillation. Thromb. Res. 2003;109:233&#x2013;240. doi: 10.1016/S0049-3848(03)00259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0049-3848(03)00259-7</ArticleId><ArticleId IdType="pubmed">12818244</ArticleId></ArticleIdList></Reference><Reference><Citation>Danese E., Montagnana M., Cervellin G., Lippi G. Hypercoagulability, D-dimer and atrial fibrillation: An overview of biological and clinical evidence. Ann. Med. 2014;46:364&#x2013;371. doi: 10.3109/07853890.2014.912835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890.2014.912835</ArticleId><ArticleId IdType="pubmed">24863960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding W.Y., Gupta D., Lip G.Y.H. Atrial fibrillation and the prothrombotic state: Revisiting Virchow&#x2019;s triad in 2020. Heart. 2020;106:1463&#x2013;1468. doi: 10.1136/heartjnl-2020-316977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-316977</ArticleId><ArticleId IdType="pubmed">32675218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding W.Y., Protty M.B., Davies I.G., Lip G.Y.H. Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovasc. Res. 2022;118:716&#x2013;731. doi: 10.1093/cvr/cvab017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab017</ArticleId><ArticleId IdType="pmc">PMC8859639</ArticleId><ArticleId IdType="pubmed">33483737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagot C.N., Arya R. Virchow and his triad: A question of attribution. Br. J. Haematol. 2008;143:180&#x2013;190. doi: 10.1111/j.1365-2141.2008.07323.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2008.07323.x</ArticleId><ArticleId IdType="pubmed">18783400</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson T., Shantsila E., Lip G.Y.H. Mechanisms of thrombogenesis in atrial fibrillation: Virchow&#x2019;s triad revisited. Lancet. 2009;373:155&#x2013;166. doi: 10.1016/S0140-6736(09)60040-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60040-4</ArticleId><ArticleId IdType="pubmed">19135613</ArticleId></ArticleIdList></Reference><Reference><Citation>Darlington A., McCauley M.D. Atrial Cardiomyopathy: An Unexplored Limb of Virchow&#x2019;s Triad for AF Stroke Prophylaxis. Front. Cardiovasc. Med. 2020;7:11. doi: 10.3389/fcvm.2020.00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.00011</ArticleId><ArticleId IdType="pmc">PMC7039862</ArticleId><ArticleId IdType="pubmed">32133372</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T. Virchow triad and beyond in atrial fibrillation. Heart Rhythm. 2016;13:2377&#x2013;2378. doi: 10.1016/j.hrthm.2016.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2016.09.007</ArticleId><ArticleId IdType="pubmed">27616698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali S., Saadat V., Co M.L., Contractor T., Mandapati R., Parwani P. Permanent left atrial thrombi after multiple atrial fibrillation ablations: Acquired Virchow&#x2019;s triad? HeartRhythm Case Rep. 2022;8:715&#x2013;718. doi: 10.1016/j.hrcr.2022.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2022.07.015</ArticleId><ArticleId IdType="pmc">PMC9596357</ArticleId><ArticleId IdType="pubmed">36310720</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvanitis P., Johansson A.K., Frick M., Malmborg H., Gerovasileiou S., Larsson E.M., Blomstr&#xf6;m-Lundqvist C. Recent-onset atrial fibrillation: A study exploring the elements of Virchow&#x2019;s triad after cardioversion. J. Interv. Card. Electrophysiol. 2022;64:49&#x2013;58. doi: 10.1007/s10840-021-01078-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-021-01078-9</ArticleId><ArticleId IdType="pmc">PMC9236986</ArticleId><ArticleId IdType="pubmed">34689250</ArticleId></ArticleIdList></Reference><Reference><Citation>Freestone B., Lip G.Y.H. The endothelium and atrial fibrillation. The prothrombotic state revisited. Hamostaseologie. 2008;28:207&#x2013;212. doi: 10.1055/s-0037-1617102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617102</ArticleId><ArticleId IdType="pubmed">18836646</ArticleId></ArticleIdList></Reference><Reference><Citation>Freestone B., Chong A.Y., Nuttall S., Lip G.Y. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: Relationship to plasma von Willebrand factor and soluble E-selectin levels. Thromb. Res. 2008;122:85&#x2013;90. doi: 10.1016/j.thromres.2007.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2007.09.008</ArticleId><ArticleId IdType="pubmed">17996280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung I., Lip G.Y.H. Virchow&#x2019;s triad revisited: Blood constituents. Pathophysiol. Haemost. Thromb. 2003;33:449&#x2013;454. doi: 10.1159/000083844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000083844</ArticleId><ArticleId IdType="pubmed">15692259</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.A., Lip G.Y.H. The prothrombotic state in atrial fibrillation: Pathophysiological and management implications. Cardiovasc. Res. 2019;115:31&#x2013;45. doi: 10.1093/cvr/cvy272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvy272</ArticleId><ArticleId IdType="pubmed">30388199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S., Zimba O., Gasparyan A.Y. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow&#x2019;s triad. Clin. Rheumatol. 2020;39:2529&#x2013;2543. doi: 10.1007/s10067-020-05275-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05275-1</ArticleId><ArticleId IdType="pmc">PMC7353835</ArticleId><ArticleId IdType="pubmed">32654082</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Stergiopoulos K., Wang L., Chen L., Cao J. COVID-19 Presenting as Major Thromboembolic Events: Virchow&#x2019;s Triad Revisited and Clinical Considerations of Therapeutic Anticoagulation. Cureus. 2020;12:e10137. doi: 10.7759/cureus.10137.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10137</ArticleId><ArticleId IdType="pmc">PMC7524023</ArticleId><ArticleId IdType="pubmed">33005549</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Gonzalez F.J., Ziccardi M.R., McCauley M.D. Virchow&#x2019;s Triad and the Role of Thrombosis in COVID-Related Stroke. Front. Physiol. 2021;12:769254. doi: 10.3389/fphys.2021.769254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.769254</ArticleId><ArticleId IdType="pmc">PMC8631516</ArticleId><ArticleId IdType="pubmed">34858214</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbillon L., Fermaut M., Benbara A., Boujenah J. COVID-19, Virchow&#x2019;s triad and thromboembolic risk in obese pregnant women. Clin. Cardiol. 2021;44:593&#x2013;594. doi: 10.1002/clc.23602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23602</ArticleId><ArticleId IdType="pmc">PMC8119852</ArticleId><ArticleId IdType="pubmed">33760245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta J.L., Calcaterra G., Bassareo P.P. COVID-19, thromboembolic risk, and Virchow&#x2019;s triad: Lesson from the past. Clin. Cardiol. 2020;43:1362&#x2013;1367. doi: 10.1002/clc.23460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23460</ArticleId><ArticleId IdType="pmc">PMC7724210</ArticleId><ArticleId IdType="pubmed">33176009</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R., Enjyoji K., Schmaier A.A. Vasculopathy in COVID-19. Blood. 2022;140:222&#x2013;235. doi: 10.1182/blood.2021012250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway E.M., Mackman N., Warren R.Q., Wolberg A.S., Mosnier L.O., Campbell R.A., Gralinski L.E., Rondina M.T., van de Veerdonk F.L., Hoffmeister K.M., et al. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol. 2022;22:639&#x2013;649. doi: 10.1038/s41577-022-00762-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Panzer B., Jozkowicz A., Kopp C.W., Gremmel T., Panzer S., Koppensteiner R. Microvascular Thrombosis as a Critical Factor in Severe COVID-19. Int. J. Mol. Sci. 2023;24:2492. doi: 10.3390/ijms24032492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24032492</ArticleId><ArticleId IdType="pmc">PMC9916726</ArticleId><ArticleId IdType="pubmed">36768817</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi A., Schiuma M., Parrulli S., Torre A., Zicarelli F., Colombo V., Marini S., Villella E., Bertoni A., Antinori S., et al. Retinal vessels modifications in acute and post-COVID-19. Sci. Rep. 2021;11:19373. doi: 10.1038/s41598-021-98873-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98873-1</ArticleId><ArticleId IdType="pmc">PMC8481283</ArticleId><ArticleId IdType="pubmed">34588541</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing H., Wu X., Xiang M., Liu L., Novakovic V.A., Shi J. Pathophysiological mechanisms of thrombosis in acute and long COVID-19. Front. Immunol. 2022;13:992384. doi: 10.3389/fimmu.2022.992384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.992384</ArticleId><ArticleId IdType="pmc">PMC9709252</ArticleId><ArticleId IdType="pubmed">36466841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G., Selleri V., Roncati L., Coppi F., Nasi M., Farinetti A., Manenti A., Pinti M., Mattioli A.V. Vascular &#x201c;Long COVID&#x201d;: A New Vessel Disease? Angiology. 2024;75:8&#x2013;14. doi: 10.1177/00033197231153204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId><ArticleId IdType="pmc">PMC9895315</ArticleId><ArticleId IdType="pubmed">36652923</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee Members. Joglar J.A., Chung M.K., Armbruster A.L., Benjamin E.J., Chyou J.Y., Cronin E.M., Deswal A., Eckhardt L.L., Goldberger Z.D., et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2024;83:109&#x2013;279. doi: 10.1016/j.jacc.2023.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2023.08.017</ArticleId><ArticleId IdType="pmc">PMC11104284</ArticleId><ArticleId IdType="pubmed">38043043</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao T.F., Joung B., Takahashi Y., Lim T.W., Choi E.K., Chan Y.H., Guo Y., Sriratanasathavorn C., Oh S., Okumura K., et al. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary. Thromb. Haemost. 2022;122:20&#x2013;47. doi: 10.1055/s-0041-1739411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1739411</ArticleId><ArticleId IdType="pmc">PMC8763451</ArticleId><ArticleId IdType="pubmed">34773920</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi E.Y., Frey S.L., Winans A., Lam K.L., Kjaer K., Majewski J., Lee K.Y. Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly. Biophys. J. 2010;98:2299&#x2013;2308. doi: 10.1016/j.bpj.2010.01.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2010.01.056</ArticleId><ArticleId IdType="pmc">PMC2872264</ArticleId><ArticleId IdType="pubmed">20483339</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaels T.C.T., Liu L.X., Meisl G., Knowles T.P.J. Physical principles of filamentous protein self-assembly kinetics. J. Phys. Condens. Matter. 2017;29:153002. doi: 10.1088/1361-648X/aa5f10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1361-648X/aa5f10</ArticleId><ArticleId IdType="pubmed">28170349</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaels T.C.T., Qian D., &#x160;ari&#x107; A., Vendruscolo M., Linse S., Knowles T.P.J. Amyloid formation as a protein phase transition. Nat. Rev. Phys. 2023;5:379&#x2013;397. doi: 10.1038/s42254-023-00598-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42254-023-00598-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Seuma M., Faure A.J., Badia M., Lehner B., Bolognesi B. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer&#x2019;s disease mutations. eLife. 2021;10:e63364. doi: 10.7554/eLife.63364.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.63364</ArticleId><ArticleId IdType="pmc">PMC7943193</ArticleId><ArticleId IdType="pubmed">33522485</ArticleId></ArticleIdList></Reference><Reference><Citation>Seuma M., Lehner B., Bolognesi B. An atlas of amyloid aggregation: The impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation. Nat. Commun. 2022;13:7084. doi: 10.1038/s41467-022-34742-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34742-3</ArticleId><ArticleId IdType="pmc">PMC9674652</ArticleId><ArticleId IdType="pubmed">36400770</ArticleId></ArticleIdList></Reference><Reference><Citation>De S., Klenerman D. Imaging individual protein aggregates to follow aggregation and determine the role of aggregates in neurodegenerative disease. Biochim. Biophys. Acta Proteins Proteom. 2019;1867:870&#x2013;878. doi: 10.1016/j.bbapap.2018.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2018.12.010</ArticleId><ArticleId IdType="pmc">PMC6676340</ArticleId><ArticleId IdType="pubmed">30611780</ArticleId></ArticleIdList></Reference><Reference><Citation>Camino J.D., Gracia P., Cremades N. The role of water in the primary nucleation of protein amyloid aggregation. Biophys. Chem. 2021;269:106520. doi: 10.1016/j.bpc.2020.106520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2020.106520</ArticleId><ArticleId IdType="pubmed">33341693</ArticleId></ArticleIdList></Reference><Reference><Citation>Cawood E.E., Karamanos T.K., Wilson A.J., Radford S.E. Visualizing and trapping transient oligomers in amyloid assembly pathways. Biophys. Chem. 2021;268:106505. doi: 10.1016/j.bpc.2020.106505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2020.106505</ArticleId><ArticleId IdType="pmc">PMC8188297</ArticleId><ArticleId IdType="pubmed">33220582</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor C.G., Meisl G., Horrocks M.H., Zetterberg H., Knowles T.P.J., Klenerman D. Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution. Anal. Chem. 2018;90:10385&#x2013;10393. doi: 10.1021/acs.analchem.8b02226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.8b02226</ArticleId><ArticleId IdType="pmc">PMC6127805</ArticleId><ArticleId IdType="pubmed">30059210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepe S., Delbridge L.M. Pacemaker cell and atrial function: Unravelling how calcium initiates and regulates the heart beat and how ionic dysfunction, &#x2018;channelopathies&#x2019; and other membrane remodelling contribute to atrial fibrillation. Heart Lung Circ. 2007;16:331&#x2013;334. doi: 10.1016/j.hlc.2007.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2007.09.002</ArticleId><ArticleId IdType="pubmed">17920525</ArticleId></ArticleIdList></Reference><Reference><Citation>Thejus J., Francis J. Atrial fibrillation in cardiac channelopathies. Indian Pacing Electrophysiol. J. 2009;9:342&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2766582</ArticleId><ArticleId IdType="pubmed">19898657</ArticleId></ArticleIdList></Reference><Reference><Citation>Enriquez A., Antzelevitch C., Bismah V., Baranchuk A. Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management. Heart Rhythm. 2016;13:1878&#x2013;1884. doi: 10.1016/j.hrthm.2016.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2016.06.008</ArticleId><ArticleId IdType="pubmed">27291509</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Battrawy I., Lang S., Zhou X., Borggrefe M., Akin I. The link between atrial fibrillation and hereditary channelopathies. Europace. 2018;20:1872. doi: 10.1093/europace/euy109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euy109</ArticleId><ArticleId IdType="pubmed">29878098</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Azaam B., Darbar D. Atrial Fibrillation in Inherited Channelopathies. Card. Electrophysiol. Clin. 2021;13:155&#x2013;163. doi: 10.1016/j.ccep.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccep.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC9172630</ArticleId><ArticleId IdType="pubmed">33516393</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubscher G.J., Khan M.A., Venter C., Pretorius J.H., Kell D.B., Pretorius E. Treatment of Long COVID Symptoms with Triple Anticoagulant Therapy. 2023.  [(accessed on 1 March 2024)].  Available online:  https://www.researchsquare.com/article/rs-2697680/v2697681.</Citation></Reference><Reference><Citation>Kell D.B., Oliver S.G. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. Bioessays. 2004;26:99&#x2013;105. doi: 10.1002/bies.10385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.10385</ArticleId><ArticleId IdType="pubmed">14696046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekelj S., Sandler B., Johnston E., Pollock K.G., Hill N.R., Gordon J., Tsang C., Khan S., Ng F.S., Farooqui U. Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort study. Eur. J. Prev. Cardiol. 2021;28:598&#x2013;605. doi: 10.1177/2047487320942338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487320942338</ArticleId><ArticleId IdType="pubmed">34021576</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng A.S., Noseworthy P.A. Prediction of Atrial Fibrillation Using Machine Learning: A Review. Front. Physiol. 2021;12:752317. doi: 10.3389/fphys.2021.752317.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.752317</ArticleId><ArticleId IdType="pmc">PMC8581234</ArticleId><ArticleId IdType="pubmed">34777014</ArticleId></ArticleIdList></Reference><Reference><Citation>Siontis K.C., Yao X., Pirruccello J.P., Philippakis A.A., Noseworthy P.A. How Will Machine Learning Inform the Clinical Care of Atrial Fibrillation? Circ. Res. 2020;127:155&#x2013;169. doi: 10.1161/CIRCRESAHA.120.316401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.316401</ArticleId><ArticleId IdType="pubmed">32833571</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizwan A., Zoha A., Mabrouk I.B., Sabbour H.M., Al-Sumaiti A.S., Alomainy A., Imran M.A., Abbasi Q.H. A Review on the State of the Art in Atrial Fibrillation Detection Enabled by Machine Learning. IEEE Rev. Biomed. Eng. 2021;14:219&#x2013;239. doi: 10.1109/RBME.2020.2976507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/RBME.2020.2976507</ArticleId><ArticleId IdType="pubmed">32112683</ArticleId></ArticleIdList></Reference><Reference><Citation>Lip G.Y.H., Genaidy A., Tran G., Marroquin P., Estes C. Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach. Eur. J. Intern. Med. 2021;91:53&#x2013;58. doi: 10.1016/j.ejim.2021.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.04.023</ArticleId><ArticleId IdType="pmc">PMC8118660</ArticleId><ArticleId IdType="pubmed">34023150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollock K.G., Sekelj S., Johnston E., Sandler B., Hill N.R., Ng F.S., Khan S., Nassar A., Farooqui U. Application of a machine learning algorithm for detection of atrial fibrillation in secondary care. Int. J. Cardiol. Heart Vasc. 2020;31:100674. doi: 10.1016/j.ijcha.2020.100674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2020.100674</ArticleId><ArticleId IdType="pmc">PMC8164133</ArticleId><ArticleId IdType="pubmed">34095444</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymanski T., Ashton R., Sekelj S., Petrungaro B., Pollock K.G., Sandler B., Lister S., Hill N.R., Farooqui U. Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients. Europace. 2022;24:1240&#x2013;1247. doi: 10.1093/europace/euac016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euac016</ArticleId><ArticleId IdType="pubmed">35226101</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant P.J. Diabetes mellitus as a prothrombotic condition. J. Intern. Med. 2007;262:157&#x2013;172. doi: 10.1111/j.1365-2796.2007.01824.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2007.01824.x</ArticleId><ArticleId IdType="pubmed">17645584</ArticleId></ArticleIdList></Reference><Reference><Citation>Konieczynska M., Fil K., Bazanek M., Undas A. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Thromb. Haemost. 2014;111:685&#x2013;693. doi: 10.1160/TH13-07-0566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH13-07-0566</ArticleId><ArticleId IdType="pubmed">24306139</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaban K., Slupik D., Reda A., Gajewska M., Rolek B., Borovac J.A., Papakonstantinou P.E., Bongiovanni D., Ehrlinder H., Parker W.A.E., et al. Coagulation Disorders and Thrombotic Complications in Heart Failure with Preserved Ejection Fraction. Curr. Probl. Cardiol. 2024;49:102127. doi: 10.1016/j.cpcardiol.2023.102127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2023.102127</ArticleId><ArticleId IdType="pubmed">37802171</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S., Boltzen U., Riad A., Kallwellis-Opara A., Rohde M., Dorner A., Tschope C., Noutsias M., Pauschinger M., Schultheiss H.P., et al. Viral myocarditis and coagulopathy: Increased tissue factor expression and plasma thrombogenicity. J. Mol. Cell. Cardiol. 2008;45:118&#x2013;126. doi: 10.1016/j.yjmcc.2008.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2008.03.013</ArticleId><ArticleId IdType="pubmed">18495150</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett P.C., Silverman S.H., Gill P.S., Lip G.Y.H. Peripheral arterial disease and Virchow&#x2019;s triad. Thromb. Haemost. 2009;101:1032&#x2013;1040. doi: 10.1160/TH08-08-0518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH08-08-0518</ArticleId><ArticleId IdType="pubmed">19492144</ArticleId></ArticleIdList></Reference><Reference><Citation>Staff A.C., Redman C.W., Williams D., Leeson P., Moe K., Thilaganathan B., Magnus P., Steegers E.A., Tsigas E.Z., Ness R.B., et al. Pregnancy and Long-Term Maternal Cardiovascular Health: Progress through Harmonization of Research Cohorts and Biobanks. Hypertension. 2016;67:251&#x2013;260. doi: 10.1161/HYPERTENSIONAHA.115.06357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.115.06357</ArticleId><ArticleId IdType="pubmed">26667417</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy M., Nath A.K., Pal I., Dey S.G. Second Sphere Interactions in Amyloidogenic Diseases. Chem. Rev. 2022;122:12132&#x2013;12206. doi: 10.1021/acs.chemrev.1c00941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.1c00941</ArticleId><ArticleId IdType="pubmed">35471949</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Naharro A., Gonzalez-Lopez E., Corovic A., Mirelis J.G., Baksi A.J., Moon J.C., Garcia-Pavia P., Gillmore J.D., Hawkins P.N., Fontana M. High Prevalence of Intracardiac Thrombi in Cardiac Amyloidosis. J. Am. Coll. Cardiol. 2019;73:1733&#x2013;1734. doi: 10.1016/j.jacc.2019.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.01.035</ArticleId><ArticleId IdType="pubmed">30947929</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Naharro A., Baksi A.J., Hawkins P.N., Fontana M. Diagnostic imaging of cardiac amyloidosis. Nat. Rev. Cardiol. 2020;17:413&#x2013;426. doi: 10.1038/s41569-020-0334-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0334-7</ArticleId><ArticleId IdType="pubmed">32042139</ArticleId></ArticleIdList></Reference><Reference><Citation>Romiti G.F., Guo Y., Corica B., Proietti M., Zhang H., Lip G.Y.H., mAF-App II Trial Investigators Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial. Thromb. Haemost. 2023;123:1042&#x2013;1048. doi: 10.1055/s-0043-1769612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1769612</ArticleId><ArticleId IdType="pubmed">37247623</ArticleId></ArticleIdList></Reference><Reference><Citation>Romiti G.F., Pastori D., Rivera-Caravaca J.M., Ding W.Y., Gue Y.X., Menichelli D., Gumprecht J., Koziel M., Yang P.S., Guo Y., et al. Adherence to the &#x2018;Atrial Fibrillation Better Care&#x2019; Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients. Thromb. Haemost. 2022;122:406&#x2013;414. doi: 10.1055/a-1515-9630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1515-9630</ArticleId><ArticleId IdType="pubmed">34020488</ArticleId></ArticleIdList></Reference><Reference><Citation>Shantsila E., Choi E.K., Lane D.A., Joung B., Lip G.Y.H. Atrial fibrillation: Comorbidities, lifestyle, and patient factors. Lancet Reg. Health Eur. 2024;37:100784. doi: 10.1016/j.lanepe.2023.100784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100784</ArticleId><ArticleId IdType="pmc">PMC10866737</ArticleId><ArticleId IdType="pubmed">38362547</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield J., Abrams S.T., Jenkins R., Lane S., Wang G., Toh C.H. Amyloid-fibrinogen aggregates (&#x201c;microclots&#x201d;) predict risks of Disseminated Intravascular Coagulation and mortality. Blood Adv. p. 2024. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2023012473</ArticleId><ArticleId IdType="pubmed">38507683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton C.F., de Oliveira M.I.R., Stafford P., Peake N., Kane B., Higham A., Singh D., Jackson N., Davies H., Price D., et al. Increased fibrinaloid microclot counts in platelet-poor plasma are associated with Long COVID. medRxiv. 2024 doi: 10.1101/2024.04.04.24305318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.04.04.24305318</ArticleId></ArticleIdList></Reference><Reference><Citation>Grixti J.M., Theron C.W., Salcedo-Sora J.E., Pretorius E., Kell D.B. Automated microscopic measurement of fibrinaloid microclots and their degradation by nattokinase, the main natto protease. bioRxiv. 2024 doi: 10.1101/2024.04.06.588397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.04.06.588397</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>